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Abstract
Purpose: An epidemic of subacute optic neuropathy with sensori-neural hearing loss and peripheral 
neuropathy has affected Tanzania.
The primary objective of this thesis was:-
To describe the clinical features of the disease.
To describe the magnitude of the epidemic 
To investigate the aetiology of the disease
To determine if daily oral B-complex supplements improved prognosis.
Methods: 225 acute cases in Dar es Salaam, Tanzania and 105 acute cases in Mogadishu, Somalia 
were assessed for signs and symptoms of optic neuropathy, peripheral neuropathy, and hearing loss. 
Blood and urine samples were collected from very acute cases (< 2 weeks of disease onset) in 
Tanzania and matched controls for aetiological studies. The same Tanzanian cases were recruited to 
the treatment study, of which 209 cases came back for 1 month re-assessment and a further 173 
patients completed the three month treatment and returned for re-assessment. Ophthalmic, 
neurological and audiometric examinations were undertaken at baseline and follow-up. 
Population-based surveys were conducted in Dar es Salaam, Tanzania and Gambia to determine the 
magnitude of the epidemic.
Results: The optic neuropathy is characterised by bilateral and symmetrical loss of visual acuity and 
colour vision, and central or caeco-central scotomas. On fundoscopy hyperaemia and swelling of 
the optic discs were observed at the early stages, as all cases progressed to temporal optic atrophy 
and nerve fibre layer loss in the papillomacular bundle.
35% of the Tanzanian cases and 59% of the Somalian cases had an accompanying peripheral 
neuropathy, 65% of the Tanzanian cases and 28% of the Somalian cases had sensori-neural hearing 
loss.
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The prevalence of the epidemic in Dar es Salaam was 2.4%, while in the Gambia it was 0.03%. An 
estimated 80 000 persons in Dar es Salaam were affected by the epidemic. The disease is 
concentrated among persons aged 10-39. The poor are particularly affected.
Cyanide intoxication has been ruled out as cause. No evidence of common leber’s mitochondrial 
DNA mutations was found. Breast-feeding is the strongest known risk factor (relative risk of 
12.50). There was a deficiency in B-complex vitamins in both cases and healthy controls.
90% of cases who came for re-assessment had substantial recovery of visual acuity, colour vision 
and hearing.
Conclusions These optic neuropathy cases appear to be identical to Cuban optic neuropathy cases, 
except that they are younger. A nutritional deficiency appears to be a key component to the 
epidemic, but is not sufficient by itself to cause the disease. Other unidentified co-factors may be 
involved. B-complex supplements have resulted in substantial visual recovery for 90% of cases.
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Chapter 1 
Optic Neuropathies : Introduction &Literature review
Background:
The anterior visual pathway is susceptible to damage from toxins or nutritional deficiency. These 
disorders tend to be classified under the heading toxic/nutritional optic neuropathy, a syndrome 
characterized by papillomacular bundle damage, central or cecocentral scotoma, and reduction of 
colour vision. Both toxicity and malnutrition, acting either independently or together, have been 
implicated in the pathogenesis of these disorders. Although these problems have been classified as 
optic neuropathies, in most of these entities, the primary lesion has not actually been localized to the 
optic nerve and may possibly originate in the retina, chiasm, or even the optic tracts.
A metabolic lesion is the most likely aetiology of the selective injury affecting neurons requiring 
high energy consumption. (Sadun et al. 1994) have postulated a mitochondrial impairment of the 
cytochrome oxidase electron transport chain as a possible mechanism of neuronal injury in Cuban 
patients. Another alternative is the blockage of the oxidative decarboxylaton of pyruvate and a- 
ketoglutrate by thiamine deficiency which would prevent the eventual production of acetyl- 
coenzyme A (acetyl-CoA). Thiamine deficiency also blocks the pentose phosphate pathway by 
preventing the transketolase reaction. The actual cause(s) of this metabolic lesion could be 
neurotoxic agents, nutritional deficiencies, genetic defects, or combinations thereof.
1. Nutritional deficiencies: The peripheral neuropathies that manifest as a result of nutritional 
deficiencies have few individual characteristic signs by which to identify them, but they can be 
differentiated by observing the other symptoms of the underlying systemic disease.
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These deficiencies come in 2 forms, either an isolated deficiency (usually one of the B vitamins) or 
a complex deficiency resulting from several concurrent metabolic disorders (usually 
malabsorption).
Pathophysiology: Neuropathies assume 2 forms: (1) definite deficiency (usually B vitamins) or (2) 
complex deficiency from several concurrent metabolic disorders (usually malabsorption). The 
mechanisms of the definite deficiencies are as follows:
Thiamine deficiency
Thiamine (vitamin B-l) is found in wheat germs, the outer layer of seeds, nuts, and most 
vegetables; thiamine pyrophosphate is essential for aldehyde group transfer and is an essential 
coenzyme for glycolytic and pentose pathways o f glucose metabolism. Thiamine is needed by 4 
enzymes, pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase, and branched- 
chain alpha-ketoacid dehydrogenase. Thirty milligrams (mg) are stored in body tissue, but 
utilization is about 1-2 mg daily; recommended daily allowance [RDA] for males is 1.5 mg. A 
deficiency can cause either "wet beriberi," in which congestive heart failure is the primary 
symptom, or "dry beriberi," in which a peripheral neuropathy is the primary symptom, depending 
on the percentage of carbohydrates in the diet. Deficiencies preferentially affect the nervous and 
cardiac tissue because thiamine pyrophosphate is bound less strongly there; daily intake of less than 
0.2 mg causes discontinuous degeneration of the axonal sheath with subsequent impairment of the 
axon, producing a polyneuropathy in about 3 months. The vagal nerve is affected particularly, 
causing symptoms in the distributions of the cardiac, laryngeal, and recurrent nerves.
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Niacin deficiency: Niacin (vitamin B-3) is found in yeast, beef, pork, and chicken. The active form 
of this coenzyme, nicotinamide adenine dinucleotide (NAD), is essential for electron and acyl- 
group transfer in glycolysis. A deficiency of niacin causes pellagra.
Pyridoxine deficiency
Pyridoxine (vitamin B-6) occurs widely in plant and animal tissues, such as muscle meat, liver, 
vegetables, and whole grain cereals; vitamin B-6 consists of pyridoxine, pyridoxal, and 
pyridoxamine. It is involved in primary carboxylation and transamination, playing a role in 
metabolizing tryptophan, glycine, serotonin, and glutamate, as well as sulfur-containing amino 
acids, and it is used in the synthesis of both heme and GAB A. Deficiencies usually are associated 
with increased excretion due to isoniazid ingestion and cause a sensorimotor neuropathy and 
seizures. Pyridoxine deficiency rarely is associated with a vasculitic mononeuropathy multiplex.
The toxic effect of excessive pyridoxine consumed for an extended period of time on the dorsal root 
ganglions causes a pure sensory neuropathy. A high-protein diet increases pyridoxine requirements, 
for which the daily requirement for males is 2 mg.
Cyanocobalamin deficiency
Cyanocobalamin (vitamin B-12) is found in meat, especially liver and kidney, cheese, milk, eggs, 
and fish; this inactive precursor is converted into 2 active metabolites—methylcobalamin and 
adenosylcobalamin. Methylcobalamin is essential for folate metabolism and the formation of 
choline-containing phospholipids that are the building blocks of myelin. Adenosylcobalamin is 
required for the formation of succinyl coenzyme A, the lack of which causes impairment in the 
formation of neural lipids.
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Following ingestion, cyanocobalamin binds with intrinsic factor secreted by parietal cells in the 
stomach, enabling it to resist proteolysis. Receptors in the distal ileum then facilitate digestion. The 
liver stores 4 mg of cyanocobalamin, representing a 3-6 year supply; thus, primary deficiencies are 
rare, except in strict vegetarians and nursing infants, but manifestations of cyanocobalamin 
deficiency occasionally complicate the presence of malabsorptive disorders. These manifestations, 
which appear throughout the white matter, are a result of a focal disintegration of medullary sheath 
known as subacute combined degeneration. The daily requirement for males is 2 mg.
Pantothenic acid deficiency
Almost all foods contain this constituent of coenzyme A, the concentration of which in tissues is 10 
times that of thiamine and 50% that of nicotinic acid. Deficiencies are rare because of this large 
amount of storage, although pantothenic acid has been implicated in the pathogenesis of "burning 
foot" syndrome. The daily requirements are 6-10 mg.
Alpha-tocopherol deficiency
Alpha-tocopherol (vitamin E) is a lipid-soluble antioxidant, lack of which causes a syndrome 
resembling spinocerebellar degeneration, reversible in early stages but with devastating 
consequences if allowed to progress. The daily requirement is 10 international units.
Multi-deficiency factors
This poorly characterized syndrome of neuropathy, visual and auditory deficits is common in 
prisoner-of-war camp survivors and in tropical countries. The neuropathy is probably due to a 
deficiency of B vitamins; the sensorineural deafness is postulated to result from deficiency in 
riboflavin or B-complex vitamins, and the amblyopia, too, may be from a complex deficiency.
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2. Toxic factors 
Alcohol
Ethanol intercalates into cell membranes, increasing membrane fluidity, but it also affects many 
signal transduction proteins, including ion channels, secondary messengers, neurotransmitters, 
neurotransmitter receptors, G proteins, chaperones, and regulators of gene expression. A 
peripheral neuropathy is often the earliest symptom of chronic alcohol dependence. Peripheral 
nerve damage results from the 3 processes (about which considerable debate still exists) of (1) 
nutritional deficiency, especially thiamine (ethanol interferes with thiamine absorption in the 
intestine) but also niacin, foliate, and protein; (2) direct toxicity from abnormal products (e.g., 
phosphatidyl ethanol, fatty acid ethyl esters) and from metabolites (e.g., acetaldehyde that reacts 
with proteins to form adducts); and (3) indirect toxicity (i.e., neuropathy from hepatic dysfunction). 
Cyanide toxicity
Cyanide toxicity from Cassava or smoking has been demonstrated to produce chronic optic 
neuropathy syndrome in Africa. When prepared incorrectly, cassava can cause cyanide intoxication. 
Cassava roots, from which several foods are processed, contain cyanogenic compounds that are 
usually reduced during processing. Cyanogenic compounds, however, often remain in cassava foods 
because the methods of processing cassava roots are not 100% efficient. Although hydrogen 
cyanide is rarely detected in these foods, consumption of foods containing cyanogenic compounds 
has been shown to result in exposure to cyanide, though the amount of cyanide absorbed from a 
single meal is small.
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Cyanide is metabolized to several compounds such as thiocyanate, cyanate, formate, and 2- 
iminothiazolidine-4-carboxylic acid, but the major metabolite is thiocyanate. Thiols which are 
sources o f sulphur are required to detoxify cyanide to thiocyanate. It has been hypothesized that the 
detoxification of cyanide to thiocyanate may be impaired in cases of polyneuropathy because of a 
deficiency of thiols. This metabolism of cyanide to thiocyanate has not, however, been shown to be 
impaired, even in starvation. This may reflect the continuous release of amino acids from the lean 
body mass during starvation.
The exact mechanism(s) by which nutrtitional deficits damage the optic nerve has not been 
elucidated. Although the aetiology is likely multifactorial, most clinicians agree that in patients who 
abuse ethanol and tobacco, undemutrition is the principal cause of the amblyopia. Others believe 
that specific deficiencies in vitamin B-12, thiamine, folic acid, or any combination of these also 
play a role (Glaser 1999).
Why certain agents are toxic to the optic nerve also remains largely un-established.
Whether the unusual configuration of the vascular supply of the optic nerve head predisposes it to 
the accumulation of toxic agents has been questioned (Lessell S 1994). Toxic and nutritional optic 
neuropathies resemble each other in terms of their clinical presentation and to most of the optic 
neuropathies that present simultaneously and bilaterally (Grant 1993).
The anatomical basis of the caeco-central scotoma was first described in autopsy studies of toxic 
amblyopia, not normal anatomy (Plant et al 1990).
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3. Genetic factors
Leber’s hereditary optic neuropathy causes a well characterized sub-acute affection of the optic 
nerves, typically inherited through the maternal line. It is due to mitochondrial dysfunction, usually 
demonstrated t be a consequence of one of three pathogenic point mutations in the mitochondrial 
DNA (mDNA). (Sadun AA 2000; Howell n 1997; Chalmers RM 1999). All three of these 
pathogenic mutations affect complex I in the respiratory chain and the biochemical defect they 
induce is still unclear. Both an impairment of energy production and/or a chronic increase of 
reactive oxygen species (ROS) are the potential consequences of the underlying LHON pathogenic 
mutations leading to optic nerve degeneration (Carelli V et al, 1997; Carelli V et al, 1999).
Leber*s hereditary optic neuropathy (LHON)
The discovery that Leber's hereditary optic neuropathy (LHON) segregated in a non-mendelian, 
maternal pattern [van Senus, 1963; Erickson, 1972; Wallace et al., 1970; Nikoskelainen et al., 
1987] suggested a disorder of mitochondrial inheritance [Nikoskelainen et al., 1984a; Egger and 
Wilson, 1983]. Using a candidate approach, Wallace and co-workers screened the mitochondrial 
genome from several LHON pedigrees and discovered a point mutation at nucleotide position 
11778 responsible for the majority of cases [Wallace et al., 1988, Singh et al., 1989]. Men are 
more frequently affected with visual loss than women, comprising 80-90% of case series 
[Newman et al., 1991; Oostra et al., 1994; Riordan- Eva et al., 1995]. Analysis of 85 LHON 
families demonstrated no statistically significant differences in ratios of affected males to 
affected females with respect to mutation [Harding et al., 1995]. With the exclusion of index 
cases and siblings less than 50 years old, the best estimate of recurrence risk is 30% to brothers 
and 8% to sisters of index cases. Affected females are more likely to have affected children, 
particularly daughters, than unaffected female carriers [Harding et al., 1995].
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The onset of visual loss typically occurs between the ages of 15 and 35 years in most pedigrees. 
This broad range of ages may occur even within the same pedigree. There are no differences in 
the age of onset between different mutation groups and between secondary and index cases. The 
age of onset in females is slightly later than in males [Harding et al., 1995].
Vision loss is, typically painless but may be associated with headache, Uhthoff s symptom 
(transient worsening with warmth or exercise), eye discomfort, photopsias, limb parasthesias, and 
dizziness [Newman et al., 1991; Riordan-Eva et al., 1995]. Simultaneous, bilateral vision loss is 
reported in approximately 50% of cases. In eyes with sequential loss, the average interval to 
involvement of the second eye is 3 months but may rarely remain monocular up to 16 years of 
follow-up [Nikoskelainen et al., 1996]. The vision loss typically reaches its nadir within 2 months 
but may be slowly progressive over a period of greater than 8 weeks. Visual acuity typically 
deteriorates to worse than 20 /200 but may range from 20/20 to no light perception. Associated 
with vision loss is progressive red-green dyschromatopsia. Pupillary light responses are relatively 
preserved in comparison with those in patients with other optic neuropathies [Wakakura and 
Yokoe 1995].
Visual field defects are typically central or caeco-central absolute scotomas surrounded by a 
narrow rim of relative scotoma. The classic fundus appearance of circumpapillary telangiectatic 
microangiopathy, swelling of the nerve fiber layer around the disc, and absence of leakage from 
the disc on fluorescein angiography [Smith et al., 1973; Nikoskelainen et al., 1982b, 1984b] may 
be observed in 50% to 60% of affected patients [Newman et al., 1991; Riordan-Eva et al., 1995] 
as well as in "presymptomatic" cases and asymptomatic maternal relatives [Nikoskelainen et al., 
1982a, 1984b].
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With time, the hyperaemia and peripapillary nerve fiber layer swelling resolve, leaving temporal 
pallor and papillomacular nerve fiber layer dropout. Most patients suffer permanent, profound 
vision loss and do not experience further insults. However, even after a period of stability lasting 
up to several years, some patients may experience recovery of excellent vision in one or both 
eyes [Stone et al., 1992). Hearing loss and skeletal abnormalities such as thoracic kyphosis have 
been reported [Wallace et al., 1970 ; Mackey, 1994; Nikoskelainen et al., 1995]. Minor 
neurological symptoms may be present in some patients, including tremor, mild cerebellar ataxia, 
pathologic reflexes and sensory neuropathy [Van Senus, 1963; Wilson, 1963; Funakawa et al., 
1995; Nikoskelainen et al., 1995].
While defects in oxidative phosphorylation has been demonstrated by in vivo phosphorus 
magnetic resonance spectroscopy and in vitro muscle and blood samples [Parker et al., 1989; 
Larsson et al., 1991; Majander et al., 1991; Toscano et al., 1992; Cortelli et al., 1991], how 
mitochondrial mutations manifest the LHON phenotype is the focus of ongoing study. No animal 
models of the disease are available.
In view of the possibility of spontaneous visual recovery in LHON, reports of effective treatment 
must be interpreted with caution. Present treatment regimens are designed to increase 
mitochondrial energy production. Agents include naturally occurring cofactors in mitochondrial 
metabolism and anti-oxidants: coenzyme Q10, succinate, idebenone, vitamin K„ vitamin K3, 
vitamin C, thiamine, and vitamin B2. Limited initial experience with coenzyme Q and succinate 
in affected patients has been disappointing. At this point, no therapy has been consistently 
demonstrated to benefit patients with vision loss or to prevent vision loss among their 
asymptomatic maternal relatives.
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4- Optic neuropathies associated with central nervous system diseases
Optic neuropathy in Human Immunodeficiency Virus (HIV) infection
Visual deterioration in HIV is a common problem. At present, the magnitude of HIV-related 
neurological complications in sub-Saharan Africa is largely unknown, though at the end of 2001, 
approximately 28.5 million people were living with HIV/AIDS in this part of the world 
(UNAIDS, 2003). Ocular manifestations of HIV include retinal microangiopathy, opportunistic 
retinal infections, Kaposi’s sarcoma of the conjunctiva and eyelids, and herpes zoster 
ophthalmicus. Retinal disease occurs frequently, sometimes in association with optic nerve 
disease. Occasionally the optic nerve is selectively involved. The commonest aetiology is 
opportunistic infection. Most case reports have focused on the role of opportunistic infections 
such as syphilitic optic perineuritis, Cytomegalovirus (CMV) papillitis, varicella zoster optic 
neuritis, or cryptococcal retrobulbar neuritis (Winward et al 1989).
Other causes include toxoplasmosis and tuberculosis, as they are responsible for the majority of 
optic neuropathies in HIV patients. The concept of primary HIV optic neuropathy remained 
controversial until viral genome was isolated in the optic nerves of five patients with axonal 
degeneration ( Sadun et al., 1995). There are two ways in which HIV infection alone may be 
implicated in optic neuropathy. Firstly, there is now increasing evidence that HIV involves the 
optic nerve in a chronic process that may not be symptomatically important. HIV was assumed to 
induce optic neuropathy in 7 patients,, representing 4% of the study population and 7% of 
patients with neuro-ophthalmologic manifestations (Mwanza et al., 2004). Visual evoked 
potentials have been shown to be reduced in HIV-positive patients ( Malessa et al., 1995).
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Morphological studies have shown that the number of retrobulbar nerve fibres in patients with 
AIDS is decreased compared with normal optic nerves, even in the absence of opportunistic 
infections (Tenhula et al., 1992). Secondly, an acute optic neuropathy has been described as part 
of an MS-like syndrome in HIV-positive patients (Berger et al., 1989). Steroid responsiveness 
may be a feature of HIV-associated optic neuropathy ( Burton et al., 1998; Newman et al., 1992). 
In conclusion HIV may directly cause an optic neuropathy.
Optic neuropathy associated with Multiple Sclerosis (Devic’s Disease)
Multiple Sclerosis (MS), originally described as monophasic attack of optic neuritis and myelitis, 
may pursue a relapsing-remitting course causing severe neurological disability (Wingerchuk et 
al., 1999). Our first insights into the pathogenesis of multiple sclerosis were obtained following 
developments in histopathology in the late 19th Century. More than a century later, despite the 
advanced molecular tools that are now available, significant progress in unravelling the 
pathogenesis of multiple sclerosis is still very much dependent on similar approaches. The 
inaccessibility of the CNS for direct study, and the clinical and genetic heterogeneity of multiple 
sclerosis combine to make the study of multiple sclerosis difficult to say the least (Compston et 
a l ,1998)
Strikingly, all early demyelinating lesions in Multiple Sclerosis are associated with perivascular 
deposition of immunoglobulins, in particular IgM, local activation of the complement cascade 
and a marked eosinophilic infiltrate. This combination of features is relatively specific for early 
NMO lesions, but is also accompanied by immunopathological changes in the CNS such as 
macrophage/microglia activation and axonal damage that are ubiquitous in all forms of multiple 
sclerosis.
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The immunopathology of MS is highly suggestive of an antibody-dependent, complement- 
mediated pathogenesis extenuated by the recruitment and degranulation of eosinophils. The 
lesion distribution also exhibits a preference for the optic tract and spinal cord similar to that seen 
in MS. .More importantly, the inflammatory infiltrate contains large numbers of eosinophils and 
demyelination is associated with complement deposition.
Recruitment of eosinophils into the CNS was not seen in demyelinating lesions induced by the 
co-transfer of MOG-specific antisera and encephalitogenic Th-1 MOG-specific T cells in BN 
suggesting that eosinophil recruitment was dependent on a MOG-specific Th-2 T cell response. 
However, it was not possible to identify a clear highly polarized MOG-specific Th-2 T cell 
response. In particular, no enhanced secretion of the classical Th-2 associated-cytokine IL-4 was 
observed and the MOG-specific antibody response included both Th-1-associated (IgG2b) and 
Th-2-associated (IgGl and IgE) isotypes.
Nevertheless, despite our limitations in understanding the genetics, immunology and cellular 
biology of MS, the findings of Lucchinetti and colleagues are of substantial therapeutic 
importance. NMO is associated with clearly defined MRI and CSF abnormalities that should 
allow us to rapidly identify these patients
Currently it is not possible to identify any o f the specific immunopathological features associated 
with variants of multiple sclerosis such as NMO using non-invasive imaging techniques, 
although developments in MRI techniques may soon bridge this gap. Once this goal is achieved it 
will be possible to identify the pathomechanisms driving disease activity and nourishes the hope 
that ‘personalized’ therapeutic approaches can be developed for defined multiple sclerosis 
subtypes.
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5- Epidemics of optic neuropathies in the world
The tropics are situated along the equator, between the tropics of Cancer and Capricorn. Poor 
environmental sanitation, frequent water-borne diseases of viral, bacterial and parasitic origin, ready 
transmission of respiratory and arthropode-bome diseases, and a high prevalence of nutritional 
deficiencies are common in the tropics (Roman 1995).
Endemic neuropathies and myleopathies are highly prevalent in the tropics ( Roman et al. 1985). In 
contrast, epidemic outbreaks, characterized by unexpected increase of incident cases over a brief 
period of time, are relatively uncommon (Schoenberg and Melton 1993).
Forms o f ' tropical amblyopia' have been reported previously in people from different parts of the 
world, including in Afro-Caribbean's in the West Indies themselves. (Strachan, 1888; Madan, 1889; 
Whitboume, 1947; Degazon, 1956) and in Afro-Caribbean immigrants to the United Kingdom 
(Crews, 1963; Owen, 1966; McKenzie and Phillips, 1968; Fasler and Rose, 1980) and the US 
(Carroll 1971).
In the 1880s, while working as a senior medical officer in Jamaica, Henry Strachan examined 
"many hundreds" of patients with "multiple neuritis." This group of patients likely consisted of 
persons with tropical Spastic Paraparesis (TSP), a syndrome predominantly affecting the lower 
limbs, is currently synonymous with human T-lymphotroic virus type I (HTLV-I) associated 
mylopathy.
Although Strachan believed that multiple neuritis was due to malaria, rather than a nutritional 
deficiency, (Miller Fisher 1955), later noted that Canadian prisoners of war subjected to 
malnourishment in Japanese concentration camps during the Second World War developed an 
ataxic neuropathy with auditory or visual loss similar to those patients described by Strachan. Fisher 
therefore named this entity Strachan's disease.
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The main feature of the Hong Kong POW (prisoner of war) neuropathy were: burning feet, 
numbness of the feet, hands and face, peripheral oedema, ataxia, impaired vision, sensory deficit for 
all modalities in the feet, usually diminished reflexes in the lower limbs, Rombergism and optic 
atrophy. Glosso-stomatitis occurred in most cases.
In 1918, Sir Henry Harold Scott (1872-1956) a past president of the Royal Society of Tropical 
Medicine and Hygiene described an outbreak of what he termed central neuritis in Jamaican sugar 
cane workers. Scott noted that the patients could be divided into patients with intestinal symptoms 
and others with nervous symptoms. Those in the latter group, referred to as the nervous cases, were 
constipated, a symptom consistent with the clinical syndrome of Tropical Spastic Paraparesis (TSP). 
Scott description of the patients' gait is consistent with the spastic gait reported in persons with TSP. 
On fundoscopy, optic atrophy and nerve fibre layer loss in the caeoco-central area are characteristic. 
Sensory neurological symptoms were noted in a proportion of cases and difficulty walking. The 
peripheral neuropathy tends to be painful and associated with ataxia when severe. Deafness is a 
common accompaniment of this syndrome. The occurrence of muco-cutaneous ulcerations in a 
proportion of cases has suggested a nutritional deficiency.
This syndrome has occurred outside the tropics in prisoners of war (Peraita, 1938). The pathological 
changes in optic nerve and spinal cord have been described both in cases from the Caribbean (Scott, 
1918) and in ex-prisoners of war (Fisher, 1955) and in peripheral nerve biopsies in Cuba (Borrajero 
et al., 1994).
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T ropical Ataxic N europathy (T AN)
An ataxic neuropathic syndrome has been described from Tanzania (Haddock et al., 1962), 
clearly associated with malnutrition in one particular outbreak ( Latham, 1964). Several 
neurological syndromes described from different tropical regions in the past century have been 
classified as tropical myeloneurpathies and further grouped into tropical ataxic neuropathy 
(TAN) and tropical spastic paraparesis. (Strachan 1897; Cruickshank e. 1946; Money 1958; 
Roman 1985).
The syndromes grouped as TAN differ widely in clinical presentation, natural history, and 
response to treatment. Two of the neurological syndromes grouped as tropical ataxic neuropathy 
were described in Nigeria in the past 60 years.
In 1930, a syndrome that affected predominantly adolescent school pupils in several boarding 
schools was reported from some communities in eastern and western parts of Nigeria. (Moore 
1930; Moore 1937; Moore 1940). The main clinical features were sore tongue, angular 
stomatitis, and skin desquamations followed by optic atrophy in large proportion of cases. 
Recovery of the lesions occurred during holidays, but many affected pupils had a recurrence on 
returning to school. (Moore 1939).
The school diet, dominated by cassava food products, was implicated as causal and almost 
100% of the patients responded to improvement of diet and supplements with autoclaved dried 
yeast.(Moore 1937). Moore considered the disorder to result from vitamin B complex 
deficiency, but the syndrome of optic neuropathy, deafness and peripheral neuropathy occurring 
in the tropics has never been shown to result from a specific micronutrient deficiency, as is the 
case in the neurological syndromes accompanying pellagra and beriberi, for example. (Moore 
1939).
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The second syndrome, unlike the syndrome of the 1930s, affected middle aged and elderly 
people predominantly and its geographical distribution was limited to some communities in 
southwestern Nigeria. (Money 1958; Money 1959).
It was variously named endemic neuropathy (Money 1958), degenerative neuropathy 
(Osuntokun et al. 1969), tropical nutrition neuropathy (Osuntokun 1971) and tropical ataxic 
neuropathy (Osuntokun 1968). Different combinations of sensory polyneuropathy, bilateral 
optic atrophy, bilateral neurosensory deafness, and sensory gait ataxia were found. Its causation 
was attributed to dietary cyanide from the monotonous consumption of food ( Monekosso 1964; 
Osuntokun 1981) processed from the starchy roots of cassava (Manihot esculenta esculenta). In 
contradistinction to the first syndrome, cases did not respond to improvement in diet or vitamin 
supplementation ( Osuntokun 1970; Osuntokun 1974).
In the 1980s, the occurrence of TAN was reported to have subsided because cases were no 
longer registered in the teaching hospitals. It was speculated that improvement in diet, which 
followed the oil boom economic recovery period of the 1970s in Nigeria, caused the 
disappearance of the syndrome (Osuntokun 1994). However, a recent food survey in Ososo, a 
semiurban community of Ijebu speaking Yorubas in south-western Nigeria previously surveyed 
in 1969 (Osuntokun 1969), showed that about 80% of the population consumed foods processed 
from the starchy roots of cassava thrice daily (Onabolu 1999). TAN remains endemic in Ososa, 
Nigeria, and it seems distinct from Strachan's syndrome, epidemic optic neuropathy in Cuba and 
Tanzania, and Konzo. However it shares feature with a subset of cases described from prisoner 
of war camps ((Oluwole et al., 2000).
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Tropical spastic paraparesis ; A condition characterized as a 'tropical' spastic Paraparesis, 
with minimal sensory deficit, was described first from Zaire, where it is known as 'Buka-buka, 
Kitondji or Konzo' in local languages (Carton et al., 1986). Acute as well as chronic spastic 
paraparesis of unknown origin is much more common in tropical countries than in temperate 
climates. Deficiencies or toxicities due to primitive diets as well as infectious agents have been 
implicated (Spillane 1973).Sometimes these diseases occur in epidemics. The earliest 
documented cases of epidemic spastic paraparesis in the Bandundu region of Zaire occurred in 
1928, 1932 and 1937 (Trolli 1938; Lucasse 1952).
Ever since there have been new outbreaks affecting hundreds of cases in several areas of 
bandundu, the latest ones in 1978 and 1981. One of the latest outbreaks was observed in 1981 in 
Masi-Manimba affecting 200 women and children (Anonymous 1982). Between epidemics, 
there have been new sporadic cases every year. For example, since a first upsurge in the area of 
Kimbongo in 1978 leading to hospitalisation of 67 patients, five to seven new cases are seen 
each year at the Hopital/Dispensaire. In Zaire the disease appears to be restricted to the 
administrative region of Bandundu but it is also rampant in the neighbouring northern part of 
Angola and in a drought-affected area in Mozambique ( Ministry of Health, Mozambique 
1984a).
The disease is characterised by a sudden onset of bilateral spastic paresis of the lower limbs, 
often associated with speech disorders and visual complaints. Recovery may be complete but 
some patients are left with a typical spastic gait, and more rarely with dysarthria.
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The clinical picture is conspicuously uniform. Without preceding illness or prodromal 
symptoms, the patients start complaining of painful paraesthesiae in the legs, and within a few 
hours or days develop weakness of the lower limbs, often with visual complaints consisting 
mainly of visual impairment, temporal pallor of the optic disc. There are visual field defects, the 
most frequent being concentric constriction and peripheral defects. No correlation was found 
between the severity of the motor disability of Konzo and the extent of visual field loss. In 
conclusion, Konzo is associated with optic neuropathy and few patients had pendular nystagmus 
in primary gaze.
The optic neuropathy in Konzo is thought to be due to cyanide toxicity, and it does not however, 
resemble the features of the epidemic optic neuropathy in Tanzania, Cuba or Nigeria, Leber's 
hereditary optic neuropathy, tobacco amblyopia or vitamin B deficiency.( Mwanza et al., 2003). 
In a study of visual evoked potentials in Konzo patients, it was found that there were delayed 
PI 00 latency and decreased amplitude. These findings indicated presence of axonal loss in the 
prechiasmal visual pathways in Konzo ( Mwanza et al 2004)
This form of spastic paraparesis differs but shows similarities with other forms of 
myeloneuropathies reported from populations in tropical countries ( Cruickshank, 1976; Roman 
et al., 1985). Lathyrism, is the tropical myelopathy most similar to Konzo, except for the 
absence of visual disturbances. It is characterized by the same acute onset of permanent 
selective damage to the upper motor neurons affecting the same age group in epidemics during 
food shortage periods. Lathyrism is caused by high consumption of the drought-resistant 
chickling pea (lathyrus sativus), a crop that does not exist in any of the areas affected by konzo, 
but consumed in parts of Ethiopia, India and Bangladesh ( Ludolph et al., 1987).
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The overall similarity between lathyrism and konzo suggests a similar or common final 
pathogenic mechanism. Recent experimental work has shown that the excitatory amino acid 
beta-N-oxalylamino-L-alanine (BOAA) found in the chickling pea and having chemical 
relationship to the amino acid beta-N-methylamino-L-alanine (L-BMMA) is likely to be 
causally associated with lathyrism ( Spencer et al., 1986).
This disorder has been convincingly shown to be related to subacute cyanide toxicity from 
poorly processed cassava in the diet. This sustained high blood cyanide concentrations are 
maintained by a deficient sulphur intake, impairing cyanide to thiocyanate conversion 
(Tylleskar et al., 1991; Tylleskar et al., 1992 ). Identical cases have been reported from 
Mozambique (Casadei et al., 1990) and Tanzania (Howlett et al., 1990) where it has been 
associated with optic neuropathy -- 8 of 24 cases had visual loss and 6 had temporal optic 
atrophy ( Milingi et al., 1991). This condition is now clearly distinguished from human T-cell 
leukaemia virus-1 ( HTLV-1) associated myelopathy ( Rodgers-Johnson et al., 1988), which is 
also a cause of spastic paraparesis in the tropics.
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Cuban Epidemic Optic Neuropathy
Introduction
A M I
Fig 1.1: The map of Cuba: (Prevalence of Optic Neuropathy): Pinar del Rio province in 
the west recorded the highest prevalence, and Guantanamo in the east had the lowest 
prevalence (Mission to Cuba PAHO/WHO 1993).
Cuba: Population is 11 million; land area is 111.000 sq km. The government continues to 
balance the need for economic loosening against a desire for firm political control. The 
government reluctantly allows a large dollar market sector, fuelled by tourism and remittances 
from Cubans abroad. In 1991, with the collapse of the Soviet Union, Cuba has lost the Soviet 
economic aid which was bankrolling the whole economy, resulting in an economic depression. 
The loss of the Soviet economic aid, combined with the US complete embargo to Cuba has led 
to a large section of the population being susceptible to nutritional disorders.
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Cuba recently endured an epidemic of neuropathy that resulted in more than 50 000 patients ( 
Mission to Cuba PAHO/WHO 1993). The index cases first noticed loss of vision in November 
of 1991, Subjects were middle-age men living in Pinar del Rio, a rural province situated at the 
westernmost end of the island and famed for the world's finest tobacco plantations.
The first 8 patients with visual loss sought medical attention in January 1992 at the 
ophthalmology service of the Abel Sant Maria Hospital in the city of Pinar del Rio and were 
diagnosed as retrobulbar optic neuritis. New cases followed with an incidence ranging between 
14 and 36 new cases per month. By July of 1992 the cumulative total had increased to 168 
cases. Tobacco-alcohol amblyopia was considered the most likely aetiology in the first cases.
In August of 1992, in the city of Cienfuegos, 22 inmates from the Ariza Prison were admitted to 
the Alderegia Provincial hospital with oedema and painful dysesthesias of the feet and legs, 
difficulty walking, sensory ataxia, and weakness. Onset was preceded by recurrent diarrhoea 
due to giardiasis or amoebic dysentery, as well as profound weight loss. Beriberi was suspected 
and patients responded to treatment with thiamine, B-group vitamins and appropriate diet. ( 
Espinosa et al., 1993).
At the end of the first year 472 patients had been reported from 6 of 14 provinces of Cuba: 
Pinar del Rio, la Habana, Cienfuegos, Holgun, Sancti Spritus and Santiago del Cuba. Three 
months later the number had escalated to 4461 cases. On March 20, 1993 a task Force 
coordinated by the Civil Defence for Disaster Relief, the Ministry of Public Health and the 
Cuban Academy for Sciences was organized to confront the growing problem. The President of 
the State Council, Fidel Castro, chaired this group. 6 research groups were formed: 
epidemiology, toxicology, basic sciences, nutrition, clinico-therapuetic, and food resources.
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Between March and April 1993 an island-wide initiative was launched to increase case 
ascertainment and to promote early treatment.
Approximately 18 000 family doctors of Cuba’s unique community-based primary health care 
system ( Teja Perez et al., 1992) were employed for this effort. Each family doctor cares for 
about 100 families and this initiative resulted in a 40% surge of incident cases increasing the 
cumulative total to 11797 cases (Ramirez et al., 1993). The number of reported cases of 
peripheral neuropathy continued to increase. These occurred either as isolated neuropathies, or 
associated with optic neuropathy, deafness, or both. Also during April of 1993, patients with 
prominent ataxia and pyramidal involvement were admitted to the Satumino Lora hospital in the 
city of Santiago de Cuba. A dorsolateral myeolpathy, probably related to vitamin B12 deficiency, 
was suspected ( Estrada Acosta et al. 1993 ). During March, April and may of 1993 the 
epidemic curve reached an irregular plateau with a cumulative total of 45 584 cases.
Finally, by early June a precipitous drop in incidence occurred. A temporal association was 
noted between the decline in cases and the distribution to the entire population of Cuba of a 
vitamin supplement containing B-group vitamins, folate, and vitamin A. Distribution began in 
the first week of May, 1993. During the last semester of 1993 incident cases gradually abated 
and by the year's end the epidemic vanished. The total number of cases officially tallied at 50 
862 of January 14 1994.
At the closing of the 32nd epidemiological week ( 7 August 1993) a total of 50 253 cases had 
been reported for an overall cumulative incidence rate (CIR) per 100 000 inhabitants of 461.64 
for all forms of the disease. According to the preponderance of visual or peripheral nerve 
symptoms, cases were classified for epidemiological purposes as optic forms (CIR 242.39) or 
peripheral forms (CIR 219.25). However, combined forms were also quite common.
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Age distribution showed minimal number of cases in adolescents and children younger than 15 
years of age, in pregnant women, and elderly people age 65 and older. Most cases (87%) 
occurred between ages 25 and 64 years. Optic forms predominated in the age group 45 to 64 
years, being slightly more common in men than in women. In contrast, peripheral forms 
occurred most commonly in women between 25 and 44 years of age. Overall the large majority 
of patients ( 93%) lived in urban areas and there was a slight preponderance of men ( 52%). 
There were no fatalities attributable to the epidemic neuropathy.
The geographic distribution showed a west-to-east pattern of decreasing incidence with very 
high rates in Pinar del Rio and few cases in Guantanamo. Evidence of contact was low among 
patients and there was no evidence of contagion (Mission to Cuba PAHO/WHO 1993). A 
number of case-series and case-control studies were performed by the Cuban Task Force 
Epidemiology Group ( Grupo Operative Nacional 1993).
A study o f4022 patients from Pinar del Rio was interviewed to define their social, occupational 
and demographic characteristics. The patient’s history of toxic exposure, nutritional history, as 
well as possible predisposing factors were also reviewed. The main finding was a strong 
association of the optic form to smoking (74%) and weight loss (79%).
Furthermore, up to 81% of the patients with peripheral form and 85% of those with combined 
forms mentioned weight loss preceding the onset of symptoms. Additionally, case-control 
studies including 708 age- and sex-matched pairs nationwide were performed (Instituto 
Nacional de Higiene 1993). Distribution by age, sex, and clinical form in these samples 
reflected national trends.
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These studies confirmed the increased risk of disease development in those with smoking 
history ( odds ratio (OR) 4.9 and 95% confidence interval (Cl) 2.5-9.3), history of irregular diet 
consumption ( missing one or more meals per day with lower intake of animal protein, fat, and 
vitamin B-rich foods) (OR 4.7 (2.5-8.8), combined smoking and drinking history (OR 3.5 (1.7- 
7.4). weight loss (OR2.8 (2.2-3.6); and heavy drinking (OR 2.3 (1.0-5.4)) ( Mas Bermejo and 
colleagues 1993). Pesticide exposure and contact in the same household with persons affected 
by the disease carried no increased risk (Mas Bermejo et al. 1993).
Clinical Aspects: A wide variety of clinical features were observed in the course of the epidemic 
including the following: (1) optic neuropathy, (2) sensory peripheral neuropathy, (3) 
dysautonomic neuropathy, (4) dorsolateral myeloneuropathy, (5) sensorineural deafness, (6) 
dysphonia and dysphagia, (7) spastic paraparesis, and (80 mixed forms.
Inclusion criteria admitted as "suspected case" any person consulting in Cuba during 1992 and 
1993 because of visual symptoms or peripheral sensory symptoms, or both, with subacute onset 
(between 3 and 30 days) and usually in association with weight loss, lack of energy and easy 
fatigability (IPK 1993). Diagnostic evaluation and confirmatory tests were performed by teams 
of experts located in 60 diagnostic centres in all the provinces.
Teams included internists, ophthalmologists and neurologists equipped with ophthalmoloscope 
instruments, tangent screens for visual testing, Ishihara plates, contrast sensitivity tests, 128- 
cycle tuning forks, and clinical neurophysiology equipment for nerve conduction studies and 
evoked responses.
Confirmed cases were hospitalised for treatment with intravenous B-group vitamins and folic 
acid. In addition to this basic therapy other forms of treatment were explored. Less than0.1% of 
the patients were left with moderate to severe sequelae.
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Investigation, diagnosis and treatment of this large-scale patient load required mobilization of 
Cuba's already limited resources, including a 30% increase in the number of hospital beds, 
urgent importation and air transportation of medications and supplies, training of physicians, 
production of clinical neurophysiology equipment, and purchase ( against major difficulties 
imposed by the economic embargo) of reagents and materials for research laboratories in Cuba. 
Optic neuropathy
Patients referred subacute and slowly progressive loss of vision in both eyes described as 
blurred vision, accompanied by photophobia with increased sensitivity to sunlight, 
dyschromatopsia or loss of red-green colour vision, and less frequently burning eyes, 
lacrimation and retro-ocular pain. Visual acuity was decreased bilaterally and usually 
symmetrically, ranging from moderate (20/80) to severe loss (5/400). Perception of Ishihara 
colour plates ranged from 7 of 8 to nil. Contrast sensitivity tests demonstrated losses to high and 
mid spatial frequencies in moderate cases and across all spatial frequencies in severe cases. 
Bilateral, more or less symmetric, central or caeoco-central scotomata were evident with the 
Amsler grid test, or more clearly with the threshold Amsler test using cross-polarizing lenses 
(Wall and Sadun 1986).Tangent field-testing with a white target revealed normal peripheral 
fields and confirmed the presence of central scotomata (up to 5 degrees from fixation), often 
revealing caeco-central scotomata. Minimal afferent papillary defects were seen and except for 
saccadic pursuits ocular motility was usually normal. Fundus examination revealed normal optic 
discs in most cases. About 12% of the cases presented slight hyperaemia of the optic nerve 
heads and capillary tortousity (Santiesteban et al. 1993). A typical finding in Cuban cases, was 
the presence of a wedge-shaped loss of fibres of the maculopapillary bundle (MPB), often with 
swelling of the nerve fibre layer above and below the MPB ( Sadun 1994).
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Although observed in other conditions, this finding was considered pathognomonic in the 
context of the Cuban epidemic. In advanced cases, temporal optic disc pallor occurred ( 
Santiesteban et al. 1993); Lincoff et al. 1993; Sadun et al. 1994).
Visual evoked responses (VERs) revealed moderate slowing of the pi 00 wave in two-thirds of 
the patients, mainly in those with severe visual deficits. Significant interocular differences in 
latencies were noted in half of the patients with abnormal VERs ( Santiesteban et al. 1993; 
Serrano et al. 1993). In a group of 602 patients with optic neuropathy studied by Santiesteban 
and colleagues (1993), about one-third presented with skin and mucous membranes lesions 
consistent with undemutrition, 32% had evidence of concomitant myeloneurpathy and 21% had 
hearing deficits demonstrated by audiometry.
Marked improvement of visual acuity and colour vision was accomplished in the large majority 
of patients following intravenous treatment with vitamin B complex and folic acid. Less 
satisfactory results were obtained in patients with long delays from first visual symptoms to 
vitamin treatment.
Peripheral neuropathy
Patients presented with complaints of painful dysesthesias involving the soles of the feet, less 
often also the hands, and rarely the face, the lips and the perioral region. Symptoms were 
described as "burning feet", "hot vapors", numbness, cramps in the feet and calves, tingling and 
pins-and -needles (Carbera et al. 1993; Perez 1993). Often, areas of hyperesthesia were noted 
on the feet and legs; true hyperathia was present predominating at night and interfering with 
sleep. Nerves were painful to palpation and patients complained of paresthesias in certain 
positions (pressure points) and of lancinating pains evoking those of tabes (Perez lache 1993).
37
In general, there was no motor paralysis but most patients complained of easy fatigability and 
muscle pains with exercise. Instances of bilateral foot drop with stoppage, as well as rare cases 
of paralysis of hand dorsiflexors, were seen.
These cases could have been caused by compression of lateral peroneal and radial nerves at 
pressure points due to weight loss and increased nerve sensitivity to pressure. Nonetheless, they 
could also represent true cases of a sensorimotor neuropathy such as beriberi. Often, 
neurological examination disclosed relatively mild objective findings compared with the 
severity of the subjective complaints. Patients usually had decrease or loss of vibratory 
perception distally in the limbs, and some also had decreased perception of soft touch, pinprick 
and temperature in a "stockings and gloves" distribution.
Tendon reflexes were lost or decreased distally. Varying degrees of muscle weakness could be 
demonstrated distally in the legs, but in general there was no obvious muscle wasting or 
paralysis. Motor-nerve conduction velocities were normal and sural sensory-nerve potentials 
were decreased only in severe cases. Sural nerve biopsies showed no axonal neuropathy 
affecting predominantly large-diameter myelinated axons (Borrajero et al. 1994).
Dorsolateral myeloneuropathy
These patients presented with sensory complaints similar to those described above. However, 
there was also an increase in urinary frequency, impotence in males, weakness of the legs and 
difficulty walking. Nocturia, urgency, and involuntary micturition were common but 
incontinence or urinary retention was exceptional.
Examination disclosed loss or significant decrease of vibratory perception in the feet, with 
decreased position sense, unsteadiness on Romberg test and sensory ataxia in severe cases. Gait 
alterations and frequent falls were often present.
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Reflexes were brisk in the knees with crossed-adductor responses, contracting with decreased 
ankle reflexes. Spasticity and Babinski signs were usually absent. Proximal motor weakness 
was present in approximately one third of the patients. A few patients developed spastic 
paraparesis. Somatosensory evoked responses with tibial nerve stimulation showed mild delay 
of the p40 wave (Perez et al. 1993).
Sensorineural deafness
Patients presented with complaints of hearing loss usually in association with peripheral sensory 
symptoms, visual loss, or both. Tinnitus, usually of high pitch (5-30 db, 4-8kHz) was a common 
accompaniment (Arias and Echemendia 1993). The deficit was subclinical in about 25% of the 
patients with proven loss of hearing by audiometry.
Pure tone audiometry demonstrated high frequency (4-8 kHzO) hearing loss bilateral and usually 
symmetrical. Abnormal brainstem auditory evoked responses were seen in 35% of the patients 
with abnormal audiometry (Serrano et al. 1993).
There were no associated vestibular symptoms in most patients. Although nystagmus was 
present in a few instances. Acoustic trauma and ototoxic exposure were ruled out. The pattern of 
sensorineural deafness was similar to that of presbycusis (Suga and Lindsay 1976), although 
young adults were affected, often with severe sensorineural deafness. In general, there was 
minimal return of hearing in response to treatment.
Mixed forms
In a comprehensive analysis of 356 patients studied in Pinar del Rio by Serrano and colleagues 
(1993) the following distribution of clinical forms was found: pure optic neuropathy (45%), 
optic neuropathy and myeloneurpathy (24%), optic neuropathy with hearing loss (14%), 
peripheral and optic neuropathy with deafness (7%).
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Other signs and symptoms
In addition to weight loss and lack of appetite, many patients complained of symptoms 
reminiscent of the chronic fatigue syndrome, with loss of energy, and difficulties with 
concentration and memory. Some patients presented dysautonomic symptoms, mainly a 
sensation of body heat accompanied by excessive sweating, coldness, and hyperihidrosis of 
hands and feet. Palpitations, occurring either spontaneously or following minimal efforts, were 
relatively common (Perez Lache 1993).
Overall, there was no evidence of infection or inflammation by clinical or laboratory 
parameters. Cerebrospinal fluid (CSF) examinations disclosed in some cases mild alterations of 
the blood-brain barrier (Alfaro et al. 1994) but were otherwise normal. There were no consistent 
abnormalities of electrolytes, endocrine, haematological, renal or liver function tests.
Aetiology: Nutritional Deprivation
This epidemic disease was characterized by selective involvement of just a few neuronal groups 
and axons, including the maculopapillary bundle; axons in the dorsal columns (fasciculus 
gracilis); and concurrent distal axonal degeneration of large myelinated peripheral sensory 
axons, high frequency spiral ganglion neurons of the cochlea, and distal-most pyramidal tract 
fibres. A metabolic lesion is the most likely cause of this selective injury, affecting neurons 
requiring high energy consumption.
Numerous neurotoxins, such as agents capable of producing amblyopia or scotomata, were 
excluded. In particular, methyl alcohol, organophosphate pesticides, trichloroethlyene, and 
chronic cyanide intoxication from cassava in the diet were carefully excluded. A Coxsackievirus 
was isolated in Cuban laboratories, but this could not be confirmed at the National Institutes of 
Health or two other laboratories in the United States.
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Genetic predisposition, in particular, mitochondrial DNA point mutations associated with Leber 
disease, was excluded in the group of patiens from Pinar del Rio (Newman et al. 1994).
The Nutritional origin of the epidemic appears inescapable: Early treatment of patients with B 
group vitamins produced complete remission. Distribution of vitamins to the entire population 
of 11 million Cubans rapidly curbed the epidemic (Ministry of Health, Cuba 1994; Roman 
1994).
Tanzanian Epidemic Optic Neuropathy
The ophthalmologic features of the disorder consisted of bilateral, simultaneous, usually 
painless, visual loss, which is progressive over a period of 2-12 weeks. There is a predominantly 
tritan loss of colour vision and symmetrical central or caeoco-central scotomas. On fundoscopy, 
few of these patients have been seen acutely, when either a normal optic disc or a swollen 
hyperaemic disc is seen. In some the macula was described as 'oedematous'.
After four weeks, there appeared to be pigment epithelial changes in the form of mottling, 
stippppling or clumping beneath the macula. However fluorescein angiograms did not show any 
window defect or other abnormality in the retinal pigment epithelium. Optic atrophy and nerve 
fibre layer loss in the caeco-central area are characteristic (Plant et al 1997). There is some 
evidence of spontaneous partial recovery of vision if cases are followed for one year. A 
preliminary ophthalmologic investigation in Dar es Salaam in 1990 suggested that, although the 
optic nerve was involved in most cases, a maculopathy was present in some ( Johnson 1993). 
Neurological symptoms were burning dysaethesiae and painful feet in the majority, with some 
complaining of sensory disturbance (numbness, tingling), which was painless. Nerve conduction 
studies showed evidence of a sensory axonal neuropathy with involvement of large fibres.
Motor conduction studies were normal ( Plant et al 1997).
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Sensorineural deafness, with loss particularly at lower frequencies was confirmed in all cases 
with symptoms of hearing loss. No patient had oscillopsia or any symptoms which might 
suggest severe vestibular failure and the vestibulo-ocular reflex was not impaired on clinical 
testing ( Plant et al 1997). Throughout the tropics, there are several myeloneuropathies that 
occur in geographic clusters (Roman 1985).
The two main forms of tropical myeloneuropathies (TAN and TSP) are known to have occurred 
in Tanzania. A distinct upper motor neurone disease has been observed in two remote rural 
areas (Howlett et al 1990; Mlingi et al 1991).
This appears to be identical to the condition "Konzo" described originally from Zaire, and also 
from neighbouring Mozambique. Of 42 patients with spastic paraparesis in the reported series 
from Tanzania, visual loss was noted in 8 cases, pallor of the temporal optic disc was observed 
in 6 cases, and none had hearing deficit. Seven cases of an ataxic neurological syndrome in 
Tanganyika were described in 1962, believed to be the first reported in East Africa (Haddock et 
al 1962). Reduced visual acuity was recorded in 3 and pallor of the optic discs in 4. The main 
feature was gross ataxia. A similar ataxic syndrome, without optic atrophy, was reported in 8 
prisoners (Latham 1964). Biochemical evidence in support of chronic cyanide toxicity was 
obtained in 8 patients with ataxic tropical neuropathy attending Muhimbili Hospital (Makene et 
al 1972). It is not clear how many of these had optic atrophy.
Although 8% of Dar Es Salaam’s population are from Asian or European origin, all cases of 
Tanzanian epidemic optic neuropathy have been observed in Africans. There is a tendency for 
the cases to be more common in the lower economy housing area, but not exclusively. There is 
no clustering by place of occupation. It is not clustered in families as would be expected from a 
water-borne infection or toxin (Plant et al 1997).
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The ocular findings, and the associated peripheral neuropathy, are essentially identical to the 
Cuban epidemic. The age distribution in the Tanzanian epidemic, however, is distinct as a 
younger age group has been affected than in the Cuban epidemic. Serological testing for 
syphilis has been negative. HIV testing has shown the same proportion of positives as in the 
general population (Johnson et al., 1994). There were negative results for HTLV-1 infection 
(Plant et al 1997).
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Table 1.1 Comparison between different optic neuropathies (Mwanza PhD thesis 2004)
Konzo Tropical Ataxic Tanzanian /Somalian Epidemic Cuban Epidemic Optic
neuropathy Optic neuropathy Neuropathy
Vitamin B l- 
B12
deficiencies
Tobacco
Amblyopia
Onset age 3-35
Onset type Acute
Course
Type
Vision
V. fields
40-50
gradual
Non progressive Progressive
Irreversible Irreversible
Blurred vision at Severe bilateral
onset loss
Concentrical
constriction
10-40
Acute
Progressive
Reversible
Severe bilateral loss
Optic disc Temporal atrophy Complete atrophy Temporal atrophy
Periph.constriction Cecocentral scotoma
25-45
Acute
Progressive 
Reversible 
Bilateral loss
Temporal atrophy
No 45+
predilection
Acute/gradua Gradual
1
Progressive Progressive
Reversible Reversible
Bilateral loss Bilateral loss
Atrophy Temp.atrophy
Cecocentral/central scot. Cecocentral Cecocentral scot.
scot
Colour V. Impaired Impaired Impaired Impaired Impaired
Leber’s hereditary op 
neuropathy
15-35
Gradual
Progressive 
Irreversible 
Severe bilateral loss
Atrophy 
Central scot.
Impaired
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Periph.Neu. 
S deafness 
Other signs
Aetiology
No
No
Spastic paraparesis
Cyanogenes in 
cassava?
Yes
Yes
Ataxic
gait,absence of 
tendon reflexes
Cyanogens in 
cassava?
Yes
Yes
Ataxic gait in some patients 
Unknown
Reference (Mwanza et al, 
2003)
Osuntokun et al, (Plant et al., 1997)
1971)
Yes
Yes
Decreased tendon 
reflexes
B-vitamin deficiencies (+ 
cyanide from smoke) ?
Roman, 1994)
Yes
No
Depend on 
the deficient 
vitamin
B-vitamin
deficiencies
Gill and Bell, 
1982)
No
No
None
Cyanide from 
smoke (+ 
nutritional, B12 
deficiencies) ?
Solberg et al., 
1998)
No
No
Neurologic, 
cardiac sequaelae
Genetic mitochondrial 
dysfunction (+  cyanide 
exposure)
Huponen,2001)
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Fig 1.2: The world map with areas of recorded neuropathy epidemics (Cuba, Tanzania,
Mozambique, Zaire, Nigeria)
This map shows the areas where epidemics of optic neuropathies, were reported. This apparent 
distribution might be the result of under-reporting, and the disease may be occurring in other areas 
of the world.
46
Dietary deficiency
Toxins)
High energy 
consumption
Optic
neuro
nathv
Fig 1.3: Possible inter-relations of risk factors to optic neuropathy
In all communities where the epidemic was observed, a background dietary deficiency was present 
in cases and controls. We think high energy consumption, mainly by young adults and/or possible 
dietary toxins are responsible for the disease to affect sections of the community.
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Chapter 2
Rationale, Aims and Objectives
An epidemic neuropathy has affected large numbers of teenagers and young adults of African origin 
in coastal Tanzania since 1998 (Johnson et al. 1991, 1993). Two forms of neuropathy were 
reported: an optic form, characterized by decreased visual acuity and colour vision, central 
scotomas, pallor of the optic discs, and loss of papillomacular bundle fibres; and peripheral form, 
with painful dyesthesias caused by axonal loss (Plant et al. 1997).
The previous clinical reports from Tanzania concentrated mainly on studying chronic cases, with 
very few acute cases being encountered.
Although many of the patients previously studied had symptoms suggesting non-visual neurological 
involvement, the nature of this had not been elucidated.
Previous investigations have failed to establish aetiology (Johnson et al., 1994). Serological testing 
for syphilis has been negative. HIV testing has shown the same proportion of positives as I the 
general population. There were also negative results for HTLV-1 infection (Plant et al., 1997).
The aetiology of this condition is as yet unknown, although the pattern of occurrence amongst those 
with poor nutrition had led to the belief that dietary factors play an important role. Furthermore, 
Cuban epidemic optic neuropathy cases demonstrated marked and almost dramatic recoveries, 
especially of visual acuity and colour vision following vitamin B complex supplements. The 
epidemic in Cuba has been essentially stopped by prophylaxis with vitamin B complex distributed 
throughout the country.
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The aim of the present thesis was:
1- To determine the magnitude of the epidemic in Tanzania and the Gambia.
2- To characterize more precisely the extent of the optic nerve and retina damage in the acute stages 
of the disease and their clinical presentation.
3-To carry out neurological examination in the present group all of whom presented with visual 
symptoms. The incidence and nature of the neurological involvement will assist in relating this 
epidemic to the various reports of optic neuropathy, peripheral neuropathy and myelopathy 
occurring in the tropics.
4-To ascertain etiological causes implicated in the Tanzanian optic neuropathy epidemic.
5- To determine if treating acute cases with daily oral B-complex supplements for 3 months 
improved their visual, neurological and auditory prognosis.
49
Chapter 3
Methods
The studies described in this thesis, are based on data from field, clinical, and laboratory studies 
conducted in Tanzania, the Gambia and Somalia.
Table 3.1: Study types and their locations
Country Tanzania Gambia Somalia
District Dar Es Salaam Whole country Mogadishu
Year 1996-1997 1996 2002-2003
Prevalence study Yes Yes No
Case series Yes No Yes
Etiological study Yes No No
Treatment study Yes No No
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Background Information: Fig 3.1 Tanzanian Map
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Tanzania is an Eastern African country, bordering the Indian Ocean, between Kenya and 
Mozambique. Its area is 945,000 sq km land: 886,000 sq km water: 59,000 sq km note: includes the 
islands of Mafia, Pemba, and Zanzibar. Population: 37 million, note: estimates for this country 
explicitly take into account the effects of excess mortality due to AIDS; this can result in lower life 
expectancy, higher infant mortality and death rates, lower population and growth rates, and changes 
in the distribution of population by age and sex than would otherwise be expected (July 2004 est.) 
Total fertility rate: 5.15 children bom/woman (2004 est.)
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Tanzania is one of the poorest countries in the world. The economy depends heavily on agriculture, 
which accounts for about half of GDP, provides 85% of exports, and employs 80% of the work 
force. Topography and climatic conditions, however, limit cultivated crops to only 4% of the land 
area. Tanzania adopted socialist political system from its independence, with the government 
subsidising basic commodities. In mid-eighties, the government has decided to adopt market-led 
economy, and stopped subsidising food; this has impacted on the poorest sections of society, and 
has precipitated the epidemic of optic neuropathy. Dar es Salaam, is the commercial capital with an 
estimated population of 3.8 million.
Fig 3.2: Somalia Map
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Population: 11.5 million (July 2004). Its area is 627.000 sq km. Somalia's economic 
fortunes are being driven by its deep political divisions. Economic life continues, in part 
because much activity is local and relatively easily protected. Agriculture is the most 
important sector, with livestock normally accounting for about 40% of GDP and about 65% 
of export earnings. Nomads and semi-nomads, who are dependent upon livestock for their 
livelihood, make up a large portion of the population. Livestock, hides, fish, charcoal, and 
bananas are Somalia's principal exports, while sugar, sorghum, corn, qat, and machined 
goods are the principal imports. Somalia's small industrial sector, based on the processing 
of agricultural products, has largely been looted and sold as scrap metal. Despite the 
seeming anarchy, Somalia's service sector has managed to survive and grow. 
Telecommunication firms provide wireless services in most major cities and offer the 
lowest international call rates on the continent. Mogadishu is the capital city of Somalia, 
with an estimated population of 2.5 million (2003).
Fig 3.3: Gambian Map
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Gambia is situated in West Africa, bordered by the Atlantic Ocean in the west,, and by Senegal in 
all other directions. Population: 1.4 million, land: 10.000 sq km (July 2004 est).
The Gambia has no important mineral or other natural resources and has a limited 
agricultural base. About 75% of the population depends on crops and livestock for its 
livelihood. Small-scale manufacturing activity features the processing of peanuts, fish, and 
hides.
Methods
3A- Prevalence studies: 
3A1- Dar es Salaam Prevalence study:
We used stratified systematic random sampling to select a sample of 1078 persons, 10 to 39 years 
old, in the 21 residential areas of Dar es Salaam. The sample size was calculated based on study 
design, assumed prevalence rate and power to get a statistically significant confidence intervals.
The visual acuity was measured by an ophthalmic nurse, using snellen chart, and colour vision was 
assessed using Ishihara colour vision test plates by a trained Ophthalmic nurse.
The fundi were examined by direct ophthalmoscope with the use of standard tungsten and red-free 
illumination. The author who had wide experience with the disease performed the examinations. 
The Tanzanian case definition requires each of the following to be present: visual acuity with 
pinhole or glasses correction of 6/9 or worse for both eyes, failure of at least 1 of 15 Ishihara 
colour-vision test plates for both eyes, bilateral temporal pallor of the optic discs, and bilateral loss 
of caeco-central projection of the nerve fibre layer.
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A questionnaire was designed to collect the data on age, sex, residence, occupation, neurological 
symptoms, weight loss, breastfeeding (pregnant women were asked whether they were at the same 
time breastfeeding or not), from the sampled subjects. This data was entered into a computer 
database, and analyzed using SPASS software. In calculating estimates for prevalence and 95% 
confidence limits, the survey design was taken into account.
3A2- Gambian Study:
A multistage random sampling method was used. The country was stratified into seven health 
divisions. Within each region/division a sample of districts was randomly selected using 
proportional probability sampling (PPS) and, within each selected district, a sample of settlements 
was selected, again using PPS, with stratification by settlement size (small <400 residents and large 
400+ residents). Within each settlement, a compound to compound census was undertaken to 
provide an up to date sampling frame from which a sample of compounds was selected. All 
residents within the selected compound were examined (Faal et al., 2000).
The field work was undertaken using three teams, each working in a different part of the country 
after standardization of examination methods. A two part ophthalmic examination was carried out. 
All subjects aged 5 years and older had measurement of visual acuity and an anterior segment 
examination by an ophthalmic medical assistant with a focused torch and x2 loupe. Everybody aged 
33 and over and any younger person with a visual acuity of less than 6/18 in either eye was referred 
for detailed examination by an ophthalmologist, who used a direct and an indirect ophthalmoscope 
and a hand held slit lamp in addition to the torch and loupe.
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Every person aged 35 and over also had visual fields screened with a Henson CFA3000 visual field 
analyzer, intraocular pressure measured with a Schiotz tonometer, and the optic disc inspected. 33 
cases of low vision or blindness in which optic neuropathy was a sole cause of vision loss were 
found during the survey. As part of the survey, we recorded each person’s name, the name of the 
head of their household/compound and address. Within one month of the main survey, we were able 
to return to the villages and identify each of the 33 cases. Each case was invited to attend their 
nearest eye unit (Banjul, Bansang, Basse or Farafenni) on a specific day for clinical assessment. The 
clinical assessment involved the following:
Measurement of visual acuity (snellen chart) and colour vision (Ishihara plates), Standard 
ophthalmic examination (portable slit lamp & direct ophthalmoscope), Assessment of visual fields 
(Henson field analyzer) and colour fields (red target)
Fundus photography (Kowa fx-500 c fundus camera), Peripheral nerve assessment (knee and ankle 
jerk reflexes; temperature, pain, touch and joint position sensation; movement co-ordination), 
Hearing assessment ( whisper and Rinne’s test).
Cases were also asked their clinical history ( ophthalmic and neurological questions) and lifestyle ( 
use of medicines, diet, smoking, alcohol use and any weight loss at the time of visual loss).In 
calculating estimates for prevalence and 95% confidence limits, a total number of 6873 from the 
national sample, aged 10-40 were included, to get a proper comparison with the Tanzanian survey. 
The survey design (stratified cluster random sampling) was taken into account and any excess 
sampling error arising from the design (extrabinomial variation) were incorporated into the 
calculations.
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3B- Case series studies:
3B1- Tanzanian case series study
15 Ophthalmic nurses from (Mnazi Moja, Kinondoni and M toni) which are three strategically 
located primary care clinics in Dar es Salaam were trained on case definition for a week. They were 
given visual acuity charts and Ishihara plates to screen for potential case patients and refer them to 
the dedicated study clinic. Every referred potential case was seen in the study clinic where they had 
an extensive ophthalmic and neurological examination to determine whether they were definite 
cases.
The case definition that has been employed in this study is as follows:
1 - Bilateral, simultaneous visual loss, the interocular difference in acuity being no greater than 
two lines of the Snellen chart.
2- Impaired colour vision (Ishihara plates).
3- Bilateral central or caeco-central scotomas at onset.
4- Bilateral temporal pallor of the optic nerve, and/or hyperaemia of the optic disc.
All these criteria must be present for a subject to be included as a case in this study.
An ethical committee at the Ministry of Health, Tanzania, approved the protocol of the study. 
Questionnaire:
Tanzanian Nurses trained in interviewing techniques administered a questionnaire regarding age, 
occupation, residence, place of work and exposure to any known toxic agents. The information 
collected included date of onset and how long it took for the visual loss to reach its worst level. The 
patients were asked in detail about past and present medication; their regular forms of food, and any 
weight loss in the last few months; drinks and smoking habits ( Appendixes 1,2).
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Ophthalmic examination:
A certified ophthalmic nurse determined best-corrected visual acuity, colour test with Ishihara 
pseuodo-isochromaqtic colour plates. Visual fields were charted by the author on a 1-m tangent 
screen with use of 1- to 10 mm red test objects. The author carried out slit-lamp examination and 
tonometry to exclude other causes of abnormal visual function. He then performed the fiinduscopic 
examinations. Fundus photographs were taken with a Kowa fx 50 R camera to confirm the results 
of the funduscopic examination.
Neurological examination:
The author obtained neurological histories and used bedside clinical methods to assess cranial 
nerves III to XII. Other neurological findings were based on assessment of tandem walking, heel- 
shin ataxia, vibration sensation at ankles, cotton wool sensation in lower limbs, knee and ankle jerk 
and joint position awareness.
Audiometric assessment:
A trained Tanzanian audiometry technician carried out all the audiometric measurements at the 
ENT department of Muhimbili Medical Centre. He used Bosch ST lOAudiometer, and carried out 
pure tone audiogram, and plotted his findings on an audiometric chart.
Statistical analysis:
The author entered the data into an excel data sheet and double checked it. Descriptive analysis was 
done using SPSSt for windows software. Simple, cross tabulations and multivariate analyses are 
used to show disease status ,exposure variables and to determine predictors of severe disease.
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3B2- Somalian case series study
The case definition that has been employed in this study is as follows:
1- Bilateral, simultaneous visual loss, the interocular difference in acuity being no greater than 
two lines of the Snellen chart.
2- Impaired colour vision (Ishihara plates).
3- Bilateral temporal pallor of the optic nerve, and/or hyperaemia of the optic disc.
All these criteria must be present for a subject to be included as a case in this study.
An ethical committee at the Ministry of Health, Somalia, approved the protocol of the study.
Nurses trained in interviewing techniques administered a questionnaire regarding age, sex, 
occupation, residence, place of work and exposure to any known toxic agents. The information 
collected included date of onset and how long it took for the visual loss to reach its worst level. The 
patients were asked in detail about past and present medication; their regular forms of food, and any 
weight loss in the last few months; drinks and smoking habits ( Appendix 1).
Ophthalmic examination:
A certified ophthalmic nurse determined best-corrected visual acuity, colour test with Ishihara 
pseuodo-isochromaqtic colour plates. The author carried out slit-lamp examination and tonometry 
to exclude other causes of abnormal visual function. He then performed the funduscopic 
examinations.
The author entered the data into an excel data sheet and double checked it. Descriptive analysis was 
done using SPSSt for windows software. Simple tabulations are used to show disease status and the 
exposure variables.
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3C- Aetiological studies: 
3C1: Cyanide intoxication in Tanzanian ON cases and controls
31 cases within two weeks of disease onset with complete samples, and 14 controls were recruited 
to this study. The controls were attending the same primary eye care clinic because of disorders 
such as trauma or refractive error without any clinical evidence of optic neuropathy. The controls 
had the same age and sex distribution and belonged to the same socio-economic group as the cases. 
All cases and controls were non-smokers. Urine and blood samples were taken from the cases and 
controls and stored frozen at -  20 degrees centigrade until analysis. We have carried out laboratory 
tests on urine, and serum samples at the laboratory of the Tanzanian Food and Nutrition Centre in 
Dar es Salaam. We used the method described by Lundquist et al. (1979) to determine thiocyanate 
in serum and urine. This method is used for rapid and specific measurement of thiocyanate in serum 
or urine. It involves separating thiocyanate from interfering compounds by adsorbing it on an anion- 
exchange resin that has special affinity for thiocyanate, then eluting with sodium perchlorate. The 
eluted thiocyanate is quantified by a modified Konig reaction, sodium hypchlorite being used as the 
chlorinating agent.
3C2: Leber’s hereditary optic neuropathy as a cause for this epidemic:
Whole blood EDTA samples were taken from the 31 cases and 14 controls. DNA was extracted 
from leucocytes and was then screened for the three primary mutations most commonly associated 
with LHON using standard assays. These assays were done at the neurogenetics laboratory of the 
Institute of Neurology, London, with thanks to Professor Nick Wood.
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3C3: Vitamin status of ON cases and control subjects
Different blood samples were obtained from 14 subjects who were clinically free of symptoms 
(controls), and 16 subjects who were suffering from optic neuropathy (cases). Blood samples 
obtained from venopuncture were kept frozen until analyzed in Dunn Nutrition centre in 
Cambridge.
Riboflavin levels were measured by the ratio of the activity of glutathione r Riboflavin levels were 
measured by the ratio of the activity of glutathione reductase with added FAD cofactor to the 
activity without added FAD, in vitro (EGRAC = Erythrocyte Glutathione Reductase Activation 
Coefficient). Serum folate was measured by the Abbott IMx ion capture procedure. Vitamin B12 
concentrations were measured by the Abbott IMx ion capture method. Erythrocyte aspartate 
aminotransferase is a measure of vitamin Bestatus, it increase in deficiency. Zinc levels are 
measured by Superoxide dismutase activity. This enzyme’s activity would fall with severe zinc or 
copper deficiency.
3D: Treatment study
225 acute cases of Tanzanian epidemic optic neuropathy were recruited to the treatment study. They 
were given vitamin B and multi-mineral supplements tablets (Sanatogen) to be taken daily for 3 
months (one tablet /everyday).
There were no control subjects for this study, as the Tanzanian authority granted the ethical 
approval of this study conditional to all cases receiving vitamin supplements. Ophthalmic, 
neurological and audiometric examinations were undertaken at baseline and follow-up visits (1 
month and 3 months).
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Table 3.2: vitamin and mineral contents of Sanatogen tablets (Roche)
Typical values % RDA Per tablet
Vitamin A 100 800pg
Vitamin D 100 5pg
Vitamin E 100 10 mg
Vitamin C 100 60 mg
Thiamine 100 1.4 mg
Riboflavin 100 1.6 mg
Niacin 100 18 mg
Vitamin B6 100 2 mg
Folic Acid (Folacin) 100 200 pg
Vitamin B12 100 1 Pg
Biotin 100 0.15 mg
Pantothenic Acid 100 6 mg
Beta Carotene 400 pg
Lutein 275 pg
Vitamin K 30 pg
calcium 22 173 mg
Phosphorus 18 144 mg
Iron 100 14 mg
Magnesium 40 120 mg
Zinc 100 15 pg
Iodine 100 150 pg
Copper 2 mg
Boron 150 pg
Chloride 36.3 mg
Chromium 25 pg
Manganese 2.5 mg
Molybdenum 25 pg
Nickel 5 Pg
Potassium 40 mg
Selenium 25 pg
Silicon 2 mg
Tin 10 pg
Vanadium 10 pg
62
Chapter 4
Results
4A- Prevalence Studies 
4A1: Tanzanian community survey
A sample of 1078 were selected as a sample, of whom 927 ( 86 percent) were examined for signs 
of the disease. 57% of the examined subjects were females, while 43% were males Mean age of 
subjects was 22.1 years (standard deviation 7.5 years), for males it was 22.3 years ( SD: 2.9 yrs), 
and for females it was 22.1 years ( SD: 2.1 yrs). Twenty-two cases were identified (prevalence, 
2.4%; 95 percent confidence interval, 1.7 to 3.0 percent). 8 cases were found among the 392 males 
examined (prevalence, 2.1 per cent), and 14 among the 535 females examined (prevalence, 2.7 
percent). The female age group 20 -  29 had the highest prevalence of 4.3 %, as for the males it was 
the age group 1 0 -1 9  with the highest prevalence at 2.6%.
Table 4.1: Age/Sex comparison between persons seen, and sampled persons not seen
Age years Males % 
Seen Not seen
Females % 
Seen Not seen
Total % 
Seen Not seen
10-19 44 43 56 57 41 39
2 0 -2 9 37 39 61 61 40 37
30-39 49 48 51 52 21 24
There was no significant difference in age/sex characteristics between those seen by team, and those 
sampled person but not traced by the team.
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Table 4.2:Flow-chart of persons screened by the nurse, and confirmed cases
927 persons screened by tMHSe')
891 persons not referred' 14 referred, but did not have fee < 22 confirmed cases
Of 927 screened by the nurse,36 were referred to the ophthalmologist, who confirmed that 22 cases 
had the optic neuropathy.
Table 4.3: Prevalence of Optic neuropathy in Dar, Tanzania by Age/Sex
Age in 
years
Male
Normal Cases %
Female
Normal cases %
Total
Normal cases %
10-19 156 4 2.3 195 2 1.02 351 6 1.9
20-29 137 2 1.5 230 10 4.3 367 12 3.0
30-39 91 2 2.2 96 2 2.1 187 4 2.2
Total 384 8 2.1 521 14 2.7 905 22 2.4
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Table 4.4: Visual Acuity of 22 Tanzanian prevalent Optic neuropathy cases
Best corrected visual acuity Number %
6/9 -  6/18 16 73
6/24-6/60 6 17
Total 22 100
Over 70% of the cases had moderate loss of visual acuity, while 17% had severe visual loss at the 
time of examination. These cases were found in the community, and it is striking that they did not 
seek medical attention with this level of visual acuity loss.
Table 4.5: Colour vision of Tanzanian prevalent optic neuropathy cases
No of Ishihara plates Number %
correctly read out of 15
1 0 -1 4  10 45A
5 - 9  6 27.3
1 - 4  6 27.3
T otal 2 2  S O
45.4% of cases had mild loss of colour vision, while the remaining 54.6 of cases presented with 
moderate to severe loss of colour vision.
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Table 4.6: Symptoms of peripheral neuropathy in Tanzanian prevalent cases
Symptoms of peripheral neuropathy Number %
Numbness in legs 8 36.4
Burning sensation in legs 8 36.4
No peripheral symptoms 6 27.2
Total 22 100.0
36% of cases complained of peripheral neuropathy symptoms, mainly numbness and burning 
sensation at the legs.
Table 4.7: Hearing symptoms of Tanzanian prevalent cases
Hearing loss (self reported) Number %
Yes 7 31.8
No 13 68.2
Total 22 100.0
About 32% of cases reported having hearing loss coinciding with the onset of visual symptoms.
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Table 4.8: Other features of Tanzanian prevalent ON cases
Characteristic Number %
Stomatitis 12 54.5
Weight loss (self reported) 5 22.7
Duration of disease(months)
<6 11 50.0
6 -1 1 5 22.7
>12 6 27.3
Total 22 100.0
Stomatitis was found in 54% of cases, this is indicative of vitamin B deficiency in our cases.
Weight loss in the 2 months preceding the disease onset was reported by 22% of cases. The duration 
of the disease indicates that it has been affecting the community for many years, but has increased 
in prevalence for the last year, as 72.3% of our cases reported noticing the visual symptoms within 
one year of being examined.
67
Table 4.9: Association of Breastfeeding and Tanzanian optic neuropathy
Breastfeeding Normal Cases %
Yes 28 7 20.0
No 369 6 1.6
Not applicable 124 1 0.8
Total 521 14 2.6
Breastfeeding was a strong risk factor. Seven cases were found among the 35 women who were 
breast-feeding (20.0 percent), as compared with six cases among the 375 women of reproductive 
age who were not breast-feeding (1.6 percent; prevalence ratio, 12.5; 95 percent confidence 
interval 4.4 to 35.2). It is worth noting that pregnant women were asked whether they were 
breastfeeding at the same time or not, and were included accordingly.
4A2 Gambian Prevalence Study:
A high response rate was achieved: 90.9% (30/33) were traced and examined. The population of the 
Gambia was estimated to be 1.17 million in 1996. The population is currently growing by 4% per 
year, and life expectancy had increased from 43.5 in 1983 to 53.5 in 1993. 4 cases of epidemic optic 
neuropathy were found, among 6873 sampled persons aged 10-40. This means a prevalence of 
0.06%, with 95% confidence interval of 0.04 -  0.08. The mean age of epidemic optic neuropathy 
was 36 years ( standard deviation: 6.2 years). For males it was 33 years, and for females it was 37 
years ( standard deviation: 7.21). Females represented 75% of epidemic optic neuropathy cases in 
the Gambia.
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Table 4.10: Coverage of Gambian optic neuropathy cases
Status N %
Traced & Examined 30 90.0
Migrated 2 6.1
Not traced 1 3.0
Total 33 100.0
Table 4.11: Clinical Diagnosis of Gambian optic neuropathy cases
Diagnosis N %
Bilateral Optic Atrophy 6 20.0
Unilateral Optic Atrophy 9 30.0
Chorioretinal Scar 6 20.0
Congenital Optic disc hypoplasia + 
maculopathy
4 13.3
Other ocular pathology 5 16.7
Total Examined 30 100.0
Bilateral optic atrophy represented only 20% of all the optic neuropathy cases.
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Table 4.12: Etiology of Gambian Bilateral Optic Atrophy
Diagnosis N %
Epidemic Optic Neuropathy 4 66.6
Macular Fibrosis 1 16.7
Unknown origin 1 16.7
Total 6 100.0
Epidemic Optic Neuropathy was seen in 4 cases out of 6873 subjects aged 1 0 -4 0  years examined 
during the Gambia survey. This results in epidemic optic neuropathy prevalence of 0.06% in the 
Gambia.
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Table 4.13: Visual Acuity of Epidemic Optic neuropathy cases in Gambia
Visual Acuity N %
6/9-6 /18  1 25
6/24-6/60 3 75
Total 4 100
75% of epidemic optic neuropathy cases had moderate to severe visual loss at the time 
of the survey. These are prevalent cases diagnosed in the community.
Table 4.14: Colour Vision of Epidemic Optic neuropathy cases in Gambia
No of Ishihara plates N %
correctly read out of 15
1 0 -1 4  1 25
5 - 9  1 25
1-4 2 50
Total 4 100
50% of cases were not able to read more than 4 plates of Ishihara plate at the time of 
diagnosis.
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Table 4.15: Symptoms of peripheral neuropathy in the Gambian cases
Symptoms of peripheral N %
neuropathy
Numbness in legs 3 75
Burning sensation in legs 3 75
No symptoms 1 25
Total 4 100
75% of optic neuropathy cases complained of peripheral neuropathy symptoms, mainly 
numbness and burning sensation in the legs.
Table 4.16: Hearing symptoms of the Gambian cases
Hearing loss (self reported) N %
Yes 1 25
No 3 75
Total 4 100
25% of cases presented with hearing loss at the time of disease onset.
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Table 4.17 Other features of Gambian cases
Characteristic N %
Weight loss 2 50
Duration of disease (yrs)
< 1 yr 1 25
1-2 yrs 1 25
> 2yrs 2 50
Breastfeeding
Yes 2 50
No 1 25
Not applicable 1 25
Total 4 100
50% of cases reported weight loss at the time of disease onset. The disease is endemic 
in the Gambia as about 50% of cases had it, for more than 2 years, and only 25% of the 
cases reported noticing the visual loss within one year of being examined.
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4B: Case Series Studies:
4BlTanzanian case series study:
Table 4.18: Age/ Sex distribution of Tanzanian optic neuropathy cases
Age group in years Males
No %
Females
No %
Total
No %
10-19 46 38.4 27 25.7 073 32.4
20-29 49 40.8 55 52.4 104 46.2
30-39 25 20.8 23 21.9 048 21.4
Total 120 100.0 105 100.0 225 100.0
Age/Sex distribution of Tanzanian 
case series study
Male Fem ale
□  10-19 yrs ■  20-29 yrs □  30-39 yrs
Fig 4.1: Histogram showing Age/Sex distribution of Tanzanian cases 
225 patients matched the selection criteria and were included in the study.
Age/Sex distributions of patients are detailed in Table 1. Males represented 53.3% of 
patients, while females were 46.7%. The mean age of the patients was 25.5 years 
(standard deviation was 6.9 years). Mean age of males was 23.2 (standard deviation was 
6.8 years). Mean age of females was 23.8 years (standard deviation was 6.3 years).
74
Table 4.19: Time interval between onset of vision loss and attending Dar clinic
Interval Cases %
1 -2  weeks 031 013.8
3 -4  weeks 088 039.1
5 -8  weeks 072 032.0
9-12 weeks 034 015.1
Total 225 100.0
More than half of our patients attended the clinic, within one month of onset of vision, 
while about 14 % of cases presented within two weeks of disease onset. This is the first 
time a study on acute cases of optic neuropathy has ever been taken.
Table 4.20: Best corrected visual acuity of Tanzanian ON cases at presentation
WHO category Best visual acuity 
( with pinhole)
cases %
Adequate vision 6/9 12 5.3)
6/12 14 6.2)
6/18 28 12.4) 23.9
Visual Impairment 6/24 42 18.6)
6/36 83 36.9)
6/60-3/60 44 19.7) 75.2
Blind Cannot see 3/60 2 0.9) 0.9
Total 225 100.0
76% of cases had best corrected visual acuities less than 6/18, which is visual 
impairment category of WHO, 2 patients were categorized as blind, as their best visual 
acuity was less than 3/60.
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Table 4.21: VA at presentation in relation to duration of disease at presentation
Duration in VA at presentation Total
weeks >6/18 6/24-3/60 <3/60
<2 16 15 31
3 - 4 14 74 88
5 - 8 14 57 1 72
9-12 10 23 1 34
Total 54 169 2 225
There was no clear pattern of disease severity, in relation to duration of disease at
presentation.
Table 4.22: Best colour vision of Tanzanian cases based on 14 Ishihara test plates
No of plates seen Cases %
14 0 0.0
10-13 76 33.8
5 -9 87 38.6
1 -4 60 26.7
Unable to read control plate 2 0.9
Total 225 100.0
At presentation, 65% of cases were failing between 5-14 Ishihara plates, and the two 
blind cases were not able to see the Ishihara control plates.
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Table 4.23: Time from onset to visual loss of Tanzanian cases
Time of Visual loss Cases %
< 2 weeks 115 51.1
2 - 4  weeks 35 15.6
5 - 8  weeks 68 30.2
> 8 weeks 7 3.1
Total 225 100.0
51.1% of cases lost their vision within two weeks of diseases onset, while 97% of all 
patients had their vision deteriorated within 2 months of noticing visual symptoms.
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Table 4.24: Ophthalmic Assessment of Tanzanian cases at presentation
Ophthalmic assessment Cases %
Pupillary response
Normal 165 73.3
Slow 054 24.0
Relative Afferent Pupillary Defect (RAPD) 006 02.7
Colour field/Amsler charts
Normal 030 13.4
Abnormal 195 86.6
Central scotoma 152 67.5
Centro-caecal scotoma 039 17.3
Other scotoma 003 01.3
Not assessed 001 0.4
Optic Disc ( OD )
Normal 0 0
Abnormal 225 100
Blurred OD margins 045 020.0
Dilated OD capillaries 093 041.3
Temporal OD pallor 151 067.1
Temporal pigmentation 091 040.4
Atrophy 007 003.1
Other 005 002.2
Nerve fibre layer
Normal 1 0.4
Abnormal 224 99.6
Loss of papillo-macular bundle 155 68.9
Thickening of nerve fibre layer 180 80.0
Loss of foveal reflex 056 24.9
Other 008 3.6
Total 225 100.0
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Table 4.25: Audiometric Assessment of Tanzanian cases at presentation
Sensori-neural hearing Case %
Normal < 20 dB loss 64 34.0
Mild impairment 20 - 30 db loss 83 44.1
Moderate impairment 40 - 59 dB loss 40 21.3
Severe impairment 60+ dB loss 1 0.5
Total tested 188 100
66% of cases had sensori-neural hearing loss at presentation.
Table 4.26: Neurological symptoms reported by Tanzanian cases at presentation
symptom Cases %
Sensory symptoms in lower limbs 119 52.9
Burning sensation in feet 72 32.0
Numbness in legs 112 49.8
Constant sensory symptoms in lower limbs 40 17.8
Burning sensation in feet 21 9.3
Numbness in legs 38 16.9
Other symptoms 70 31.1
Difficulty walking 21 9.3
Difficulty controlling bladder 22 9.7
Difficulty with memory 35 15.6
Total cases interviewed 225 100
These were self-reported symptoms at the time of visual loss onset.
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Table 4.27: Neurological Examination of Tanzanian cases
Neurological examination Cases %
Signs of peripheral neuropathy
No signs 145 65
Signs of peripheral neuropathy 079 35
Total examined 224 100.0
Based on assessment of tandem walking, heel-shin ataxia, vibration sensation at ankles, 
cotton wool sensation in lower limbs, knee and ankle jerk and joint position awareness. 
About 35% of patients had signs of peripheral neuropathy at presentation, while 65% of 
patients were optic neuropathy cases.
Optic neuropathy (ON) 17%
Peripheral 
neuropathy (PN)
17%
Hearing loss 
(HL) 48%
18%
Fig 4.2: Association of Optic Neuropathy, hearing loss and peripheral neuropathy in 
Tanzanian cases.
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Table 4.28 Multivariate Analysis of Tanzanian case series
p-value Odds ratio 95.0% C.I. for odds ratio
Lower Upper
Step 1(a) age .089 2.420 1.900 6.155
Sex .079 2.217 .912 5.386
PN .110 .867 .727 1.033
HL .281 .906 .758 1.084
Smoke .316 2.112 .490 9.106
Alcohol .159 .489 .181 1.323
WL .565 1.351 .484 3.768
Disease
duration
.074 .616 .362 1.048
Constant .110 .030
Variable(s) entered on step 1: age, Sex, PN, HL, Smoke, Alcohol, WL, disease duration. 
Visual acuity (VA) was used as a predictor of disease severity, and accordingly those 
with VA 6/9 -  6/18 were considered to have mild disease, and those with 6/24 -  6/60 as 
moderate cases, and severe cases were having VA of less than 6/60 in the better eye.
No single factor was significantly associated with disease severity.
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5% 3%
30%
□ Manual ■ Entrepreneur □ Student □ Clerical ■ Farmer 
Fig 4.3: Occupation of Tanzanian cases
39% of cases were manual labourers, while further 30% were entrepreneurs. This 
shows that majority of the cases were from low socio-economic level.
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Report of Tanzanian cases 
Case 1
An 18-year old housewife from Mbagala neighbourhood of Dar es Salaam, began to 
notice a worsening of her vision. This was accompanied by burning sensation and 
numbness of her feet, difficulty in hearing and weight loss. She recognized that 
there was a severe problem when she could no longer recognize faces. After 2 
weeks from the onset of her visual symptoms she was referred to our study clinic. 
She had no prior medical problems, did not smoke or drink alcohol, but was 
breastfeeding for the last 6 months. On examination, best corrected bilateral visual 
acuity was 6/60, colour vision she could discern 3 of 14 Ishihara plates. On colour 
field testing, she demonstrated a caeoco-central scotoma in both eyes. Fundus 
examination demonstrated fairly normal fundus, apart from swollen and hyperaemic 
discs. The findings of her neurological examination were normal. She had mild 
sensori-neural hearing loss. She was started on vitamin supplements for three 
months, and came back for follow-up assessments at 1 month and 3 months from 
presentation.
At the one month follow-up assessment, her visual acuity improved to 6/12. Optic 
nerve function studies were also improved: She could discern 6 of 14 Ishihara 
plates, colour field tests were entirely normal. Fundus examination showed a 
thinning of the nerve fibre layer in the papillomacular bundle in both eyes and 
marked decrease of the optic disc swelling. At 3 month assessment, visual acuity 
was 6/4, colour vision 14 out of 14 Ishihara plates. Her hearing returned to normal, 
and the neurological symptoms disappeared. The fundus examination showed loss 
of papillomacular bundle and temporal pallor of the optic discs.
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Case 2
A 30 year-old man living in Ubongo area of Dar es Salaam and working as a car 
mechanic, was well until he noticed sudden visual symptoms, which began as a 
clouding of central vision in the left eye and progressed in a few days to the right 
eye. In a week, he could no longer work or watch television. He had no other 
medical history. He did not smoke nor drink alcohol, and did not notice any weight 
loss coinciding with the visual symptoms.
He came to our clinic within one week of onset of his symptoms. On our 
examination, best bilateral visual acuity was 6/60. He could recognize 3 of fourteen 
Ishihara plates.
Pupil examination showed both pupils to have a sluggish response to light, but there 
was no afferent papillary defect. Colour field testing showed bilateral dense central 
scotomas. A fundus examination demonstrated a normal appearing nerve fibre layer, 
and swollen and hyperaemic optic discs.
Neurological examination was normal, and there was a mild sensori-neural hearing 
loss on audiometry testing. He was started on vitamin supplements, and told to come 
back for 1 month and 3 months follow-up assessments.
On re-examination after one month of vitamin supplements, the visual acuity 
improved and was 6/9, while he could see all the 14 Ishihara plates. On fundus 
examination there was temporal pallor and loss of the nerve fibre layer in the 
papillomacular bundle.
Again at 3 month, the visual acuity further improved, and at this time his bilateral 
visual acuity was 6/4, and colour vision was 14/14, but the temporal pallor and 
nerve fibre layer loss at the papillomacular bundle remained.
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Case 3
A 15 year old student from Mtoni area of Dar es Salaam, was well, until she noticed 
that she could no longer read or recognize faces. She also noted that she could not 
see any colours and believed that her hearing was impaired bilaterally on an 
intermittent basis. She came to the clinic after 3 months from the start of her 
symptoms.
On examination, her bilateral visual acuity was 6/60. She could discern only 3 out of 
14 Ishihara plates, and there was caeco-central scotoma on testing her colour field. 
Fundus examination demonstrated severe temporal pallor of both optic discs and 
severe losses of the nerve fibre layer in the papilomaculare bundle.
General neurological examination revealed signs of peripheral neuropathy, mainly 
of decreased sensation to pinpricks and cotton wool in her legs.
After one month of vitamin supplements, the vision improved to 6/36, and colour 
vision was 6/14 Ishihara plates. At three months assessment the vision was 6/9, and 
colour vision was 14/14.The central scotoma, and the peripheral neurpathy have 
disappeared. The fundus picture remained the same, with temporal pallor of the 
optic discs, and nerve fibre layer loss at the papillomacular bundle.
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4B2- Somalian case series study:
Table 4.29: Age/Sex distribution of Somalian ON cases at presentation
Age in 
years
Male
No %
Female
No %
Total
No %
10-19 19 27.9 10 27.1 29 27.6
20-29 34 50.0 16 43.2 50 47.6
30-39 15 22.1 11 29.7 26 24.8
Total 68 64.8 37 35.2 105 100.0
65% of cases were male, compared to 35% female. The mean age of the cases was 24 
years (standard deviation 5.3 years).
Table 4.30: Visual Acuity of Somalian ON cases at presentation
Visual Acuity No %
6/9 -6 /18 20 19.0
6/24 -  6/60 75 71.5
5/60 - 3/60 10 9.5
Total 105 100.0
81% of the cases had visual impairment at the time of their presentation to the clinic.
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Table 4.31: Colour Vision of Somalian ON cases at presentation
Plates seen based on 14 Ishihara plates No %
10-14 plates 10 10
5 - 9  plates 18 17
1-4 77 73
Total 105 100
Over 70% of the cases had deteriorated colour vision, as they were able to see only 1-4 
test plates.
Table 4.32: Duration of disease of Somalian ON cases at presentation
Duration No %
< 1 month 31 30
2 - 3  months 37 35
4 - 6  months 22 21
7-12 months 13 12
>12 months 02 2
Total 105 100
30% of the cases noticed the visual symptoms for less than a month, prior to their 
presentation to the clinic.
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Table 4.33: Other symptoms of Somalian ON cases at presentation
Symptom cases
No %
Hearing loss 30 28.5
Numbness at legs 62 59.0
Weight loss 47 44.7
Smoking 10 9.5
Stomatitis 28 26.6
Breastfeeding 16 51.6%
28.5% of cases had hearing loss at presentation and 59% of cases reported having 
numbness at legs which coincided with the visual loss. 44.7% of the Somalian cases 
noticed weight loss, and 51.6% of females at breastfeeding age were breastfeeding when 
they were affected by the optic neuropathy.
Table 4.34: Age/Sex distribution of Somalian (SO) and Tanzanian (TZ) ON cases at 
presentation
Age group in years Males % 
SO TZ
Females % 
SO TZ
Total % 
SO TZ
10-19 28 38 27 26 28 32
20-29 50 41 43 52 47 46
30-39 22 21 30 22 25 22
Total 100 100 100 100 100 100
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Age/Sex distribution of Tanzanian &
Somalian ON cases
50 /
40 /
30
20 <[
10 y]
0^A
10yrs-19yrs 20yrs-29yrs 30yrs-39yrs
□  SO  a T Z
Fig 4.4: Age/Sex distribution of Tanzanian and Somalian cases was very similar, this 
supports our hypothesis that the condition is the same in the two locations.
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4C: Etiological Studies:
4C1: Cyanide Intoxication assessment of cases and controls
Table 4.35: Thiocyanate levels in serum and urine samples of cases and controls
Standard range Cases Controls
N % N %
Serum
Low <100pmol/L 31 100.0 14 100.0
High 100+pmol/L 0 0
Total 31 100.0 14 100.0
Mean (sd) 27.34pmol/L (25.7) 22.95pmol/L (24.5)
Urine
Low <100pumol/L 31 96.9 4 26.7
High 100+pmol/L 1 3.1 11 73.3
Total 32 100.0 15 100.0
Mean 36.26pmol/L (29.4) 48.42pmol/L (36.8]
There is no significant difference of thyiocyanate levels between cases and controls. ( p- 
Value of 0.31 for serum, and p value of 0.32 for urine analysis).
4C2- Leber’s hereditary optic neuropathy as a cause for the epidemic
All DNA samples were negative for the 11778, 3460 and 14484 mutations which are
found in 95% of Caucasian families with LHON.
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4C3- Vitamin Status of cases and controls:
Thiamine analysis on the Tanzanian cases and controls
The transketolaseassay of thiamine status yields a ratio of stimulated (+  cofactor) to 
basal ( -  cofactor) activities, known as ETKAC, which goes up in deficiency. A second 
related index of thiamine status is the basal TK activity, given as “Activity values” with 
a haemoglobin denominator: (this is in IU/g haemoglobin). This index goes down in 
deficiency.
Table 4.36: Erythrocyte transketolase assay (ETKAC)
Standard ratio Cases Controls
range N % N %
Normal 1.00-1.15 6 37.6 6 40.0
Marginal 1.16-1.25 5 31.2 2 13.3
Deficient >1.25 5 31.2 7 46.7
Total 16 100.0 15 100.0
Mean (sd) 1.20 (0.11) 1.20 (0.12)
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Table 4.37: Mean values and significant tests of Thiamine status
Index Mean for Tanzanian Mean for Tanzanian t-test cases vs. t-test
cases controls controls Tanzania
Mean SD (n) Mean SD (n) vs. UK
Thiamine:
(transketolase)
ETKAC 1.20 (Oil) (16) 1.20 (0.12) (15) Not
significant
t=3.53
ETK (basal) 0.56 (0.17) (16) 0.56 (0.11) (15) Not t=6.82
IU/g HB significant significant
There was no difference between cases and controls of the Tanzanian set, but the mean 
ETKAC was significantly higher than UK elderly. In the case of ETK (basal), again 
there is no difference between the cases and control, but a highly significant difference 
when compared with the UK elderly dataset (NDNS). Therefore the Tanzanian 
population is generally more deficient in Thiamine than those of the UK.
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Table 4.38: Serum folate levels of the Tanzanian cases and controls
Standard range
N
Cases
% N
Controls t-test cases vs. 
% controls
Normal 14.0+nmol/L 8 57.1 11 73.3
Marginal 7.0-13.9 nmol/L 6 42.9 4 26.7
Deficient <7.0 nmol.L 0 0.0 0 0.0
Total 14 100.0 15 100.0
Mean (sd) 16.7 (5.4 19.2 (8.8) Not significant
None of the samples fell below 7nmol/L, which is the threshold of folate deficiency. 
Table 4.39: Riboflavin ( B2) status of the Tanzanian cases and controls
Standard range Ratio Cases Controls t-test cases
N % N % vs. controls
Normal 1.00-1.29 1 0 0 0
Marginal 1.30-1.79 1
6.2
2 14.3
Deficient 1.80+ 15
93.8
12 85.7
Total 16
100.0
14 100.0
Mean (sd) 2.98 (0.67) 2.86(1.07) Not
significant
Almost all cases and controls were deficient in riboflavin.
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Table 4.40: Vitamin B12 status of the Tanzanian samples
Standard range Ratio Cases Controls t-test cases vs.
N % N % controls
Normal >223pg/ml 7 50.0 11 78.7
Intermediate 179-223 pg/ml 2 14.2 2 14.2
Deficient <179pg/ml 5 35.7 1 7.1
Total 14 100.0 14 100.0
Mean (sd) 474 (287) 330 (245) Not significant
Both cases and control had normal Vitamin B 12 levels
Table 4.41: Vitamin B6 status of the Tanzanian samples
Standard range Ratio Cases Controls t-test cases vs.
N % N % controls
Normal 1.6
2.00nmol/L
9 56.3 13
86.7
Marginal 2.0 -  2.5 
nmol/L
5 31.2 2
13.3
Deficient >2.5 nmol 2 12.5 0 0
Total 16 100.0 15 100
Mean (sd) 2.06 (0.32) 1.87 (0.22) T=1.91 (border
line)
These Tanzanian results are within the normal range, but are a little higher in cases than 
the controls.
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Table 4.42: Zinc levels of the Tanzanian samples
Standard range ratio Cases
N %
Controls
N %
t-test cases vs. 
controls
Normal 1092 -  1817 14 87.5 15 100
U/gHb
marginal 1090 -  850 2 14.5 0 0
U/gHb
Deficient < 850 U/gHb 0 0 0 0
Total 16 100 15 100
Mean (sd) 1319(252) 1302(182 Not significant
Most Tanzanian results are within the normal range, and there is no difference between 
cases and controls.
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Table 4.43: fat-soluble vitamin analysis of the Tanzanian samples 
The fat soluble vitamins are analyzed directly from plasma samples.
Tanzania controls Tanzania cases UK National Diet and Nutrition Survey
n Mean (sd) n Mean (sd) (NDNS) (65-74 y) Finch S et al (1998)
n mean (sd)
Retinol 15 0.912 (0.441) 14 0.891 (0.343) 1079 2.148 (0.648)
Alpha-tocopherol 15 17.5 (4.8) 14 19.1 (3.8) 1079 35.7 (11.2)
Gamma-tocopherol 15 0.66 (0.30) 14 0.68 (0.35) 1071 2.29 (1.10)
Retinol palmitate 15 0.108 (0.106) 14 0.075 (0.031) 1018 0.078 (0.044)
Lutein 15 0.453 (0.277) 14 0.646 (0.449) 1079 0.363 (0.188)
Alpha- 15 0.020 (0.020) 14 0.020 (0.009) 1072 0.034 (0.036)
cryptoxanthin
Beta-cryptoxanthin 15 0.075 (0.088) 14 0.071 (0.052) 1061 0.136 (0.143)
Lycopene 15 0.339 (0.171) 14 0.392 (0.202) 1072 0.249 (0.191)
Alpha-carotene 15 0.130 (0.253) 14 0.019 (0.007) 1068 0.070 (0.067)
Beta-carotene 15 0.334 (0.510) 14 0.130 (0.084) 1078 0.353 (0.236)
There was no significant difference between the Tanzanian cases and controls. There is 
clear deficiency in retinol and tocopherol levels of the Tanzanian samples compared to 
the British samples in the NDNS study.
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4D- Treatment study:
250
200
150
100
50
225
209
173
presentation 1 month 3 months
Fig 4.5: Follow-up of cases with supplements
This chart shows that 100 % of cases were seen at presentation, while 93% were seen at 
one month follow-up, and a further 77% of cases completed the 3-month vitamin 
supplements and came back to the clinic for assessment. Among those who were seen at 
3 months, there were 14 (6%) who did not come back for their 1 month assessment.
This results in only 2 cases (1%) that did not come back after their baseline assessment.
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Table 4.44: Best corrected visual acuity outcome after 1 month of vitamin supplements
WHO Best corrected 
visual acuity
Cases %
Adequate 6/6 or better 34 16.3)
can see 6/9 36 17.2)
can see 6/12 27 13.0)
can see 6/18 32 15.2) 61.7
Visual Can see 6/24 27 13.0)
impairment Can see 6/36 32 15.2)
Can see 6/60 18 08.6) 36.8
Severe visual Can see 3/60 2 01.0)
impairment
Blind Cannot see 
3/60
1 00.5) 01.5
Total tested 209 100.0
After one month of vitamin supplements, there were significant improvements in visual 
acuity. 61.7% had adequate vision, and only 36.8% had impaired vision ( Table 5.2).
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Table 4.45: Best corrected visual acuity after 3 months of vitamin supplements
WHO Best corrected 
visual acuity
cases %
Adequate vision 6/6 or better 72 41.6)
can see 6/9 33 19.1)
can see 6/12 21 12.1)
can see 6/18 21 12.1) 84.9
Visual impairment Can see 6/24 11 6.4)
Can see 6/36 15 8.7)
Can see 6/60 0 0 ) 15.1
Severe visual Can see 3/60 0 0
impairment 0 0
Blind Cannot see 
3/60
Total tested 173 100.0
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Table 4.46: Visual gain of ON cases after 1 month of vitamin supplements
VA at presentation
Adequate vision 
6/6-6/18
Adequate vision 
6/6-6/18 
41
Impaired vision 
6/24 -6/60 
86
S.I/Blind
<6/60
2
Total
129
VA at 1 month Impaired vision 
6/24 6/60
73 4 77
Severely
impaired/Blind
<6/60
3 3
Total 41 159 9 209
159 (76.01%) cases of those assessed after 1 month of vitamin supplements had recovered part of their visual acuity, while 47 (22.5%) of 
cases did not continue to lose their visual acuity. Only 3(1.4%) cases had their visual acuity deteriorated after one month of vitamin 
supplements.
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Table 4.47 Visual gain of ON cases after 3 months of vitamin supplements
VA at presentation
Adequate vision 
6/6 -6/18
Impaired vision 
6/24 - 6/60
S.I/Blind
<6/60
Total
Adequate vision 
6/6-6/18
37 106 4 147
VA at3 months Impaired vision 
6/24 -  6/60
S .Impaired/Blind 
<6/60
25 1 26
Total tested 37 131 5 173
Not tested 2 3 5 9 15 14 4 52
Total 7 12 28 42 82 45 9 225
158 (91.3%) of cases assessed after 3 months of vitamin supplements had gained in vision, while 15 (8.7%) had maintained their 
presentation vision. There was no single case that experienced a deterioration of vision, once started on vitamin supplements.
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Table 4.48: Colour vision based on 14 Ishihara plates of cases on vitamin supplements
No of plates seen Presentation 1 month of vitamin 3 months of vitamin
supplements supplements
No % N % N %
14 0 9 4.3 17 9.8
10-13 76 33.8 140 67.0 122 70.5
5 - 9 87 38.6 26 12.4 20 11.6
1-4 60 26.7 33 15.8 14 8.1
Unable to see 2 0.9 1 0.5 0
Total tested 225 100.0 209 100.0 173 100.0
At presentation only 33.8% of cases were able to see 10-13 Ishihara colour plates.
Following vitamin supplements, as the number of cases able to see 10-13 plates
increased to 71.3 % after 1 month, and 80.3% after 3 months of follow-up.
Table 4.49: Audiometric Assessment of ON cases on vitamin supplements
Sensori-neural At presentation 1 month F/UP 3 months F/UP
hearing loss N % N % N %
No loss 64 34.0 135 81.8 137 90.1
Mild loss 20 -  30 dB loss 83 44.2 7 4.2 7 4.6
Moderate loss 40 -  59 db loss 40 21.3 11 6.7 8 5.3
Severe loss > 60 dB loss 1 0.5 12 7.3
Total tested 188 100.0 165 100.0 152 100.0
At presentation, only 34% of cases had normal hearing tests on audiometry. 81.8% 
cases had normal tests after 1 month, and 90.1 were tested normal after 3 months of 
vitamin supplements.
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Table 4.50: Neurological assessment of ON cases on vitamin supplements
Signs of peripheral At presentation 1 month F/UP 3 months F/UP
neuropathy N % N % N %
No signs 145 64.7 128 62.1 124 73.0
Signs of p. 79 35.3 78 37.9 46 27.0
neuropathy
Total tested 224 100.0 206 100.0 170 100.0
Based on assessment of tandem walking, heel-shin ataxia, vibration sensation at ankles, 
cotton wool sensation in lower limbs, knee and ankle jerk and joint position awareness.
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Chapter 5
Discussion, Conclusions & Recommendations
5A: Prevalence studies: 
5A1: Tanzanian prevalence study
On the basis of a prevalence of disease of 2.4 percent (95% confidence interval of 1.7 to 
3.0 per cent) and the patterns of presentation at health clinics, we estimate that there 
were 40 000 persons were affected with optic neuropathy in Dar es Salaam at the time 
of this study. Not included in this study are people with isolated peripheral neuropathy, 
who seek care at primary health clinics with the same frequency as those with optic 
neuropathy.
Our estimate is that 80 000 persons in Dar es Salaam have the disease, of whom:
• 25 000 persons have pure optic neuropathy
• 40 000 persons have pure peripheral neuropathy
• 15 000 persons have both optic and peripheral neuropathy
This disease mainly affects persons aged 1 0 -4 0  years. Groups at particular risk of 
disease are: adolescent youth, pregnant women, lactating women and the very poor. The 
strongest known risk factor is breast-feeding (relative risk: 12.5).
The cause of the epidemic is unknown. Cyanide intoxication from improperly processed 
cassava and tobacco smoking have been ruled out (Plant et al., 1997).Mitochondrial 
DNA analysis have not shown any common mutations associated with Leber’s 
hereditary optic neuropathy ( Plant et al., 1997).
The disease is clinically identical to the recent epidemic of bilateral optic neuropathy 
seen in Cuba (the Cuba Neuropathy field Investigation team 1995). That epidemic 
resulted in more than 50 000 patients (Mission to Cuba PAHO/WHO 1993).
104
Our survey data suggests that the Tanzanian epidemic neuropathy is the largest outbreak 
of epidemic neuropathy ever reported. The social and economic consequences of the 
disease are enormous. Persons with the disease, if  left untreated, are unlikely to be able 
to undertake any form of employment or education for the remainder of their lives. With 
an estimated 80 000 affected persons, the epidemic must be having a devastating impact 
on the meagre community health services. This is likely to lead to overloading of the 
health services, and a drain on their already limited resources.
5A2: Gambian Prevalence study
Clinical review of bilateral optic neuropathy cases identified in the 1996 national survey 
of blindness in the Gambia identified 4 epidemic optic neuropathy cases. These are non­
epidemic cases and indicate background rates in a non-epidemic situation.
The prevalence of epidemic optic neuropathy in the Gambia was 0.05 %( 95% 
confidence interval, 0.01 to 0.05%), compared to 2.4% in Dar es Salaam. This means 
that the prevalence in Dar es Salaam is 48 times higher than in the Gambia.
The clinical characteristics of the Gambian epidemic optic neuropathy cases are very 
similar to the Tanzanian cases, except that the Gambian cases seem to be older than the 
Tanzanian ones.
This study provides, for the first time, a detailed description of cases of optic atrophy 
and neuropathy as they occur in an unbiased random sample of a population. 
Undoubtedly, it enlarges the clinical understanding of optic neuropathies in general, 
plus provides a unique data on their prevalence in a coastal West African country
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5B- Case series studies:
These studies provide a clinical description of the acute stage of the epidemic 
neuropathy in Tanzania and Somalia. Our design, using fundoscopic abnormalities, plus 
field defects to define case-patients status and excluding any other patient, gave a 
rigorous assignment of case patient.
The rapid referral system was successful in identifying acute cases with recent onset of 
visual loss in Tanzania. Several cases presented to the clinic within 2 days of disease 
onset.
Ophthalmic findings
The prominent clinical features were bilateral loss of visual acuity with central or 
centro-caecal scotomas and diminished colour vision. The optic discs were either 
normal, or with dilated capillaries and blurred margins in the early acute cases. These 
are classic signs of acute inflammation of the optic nerve. After four weeks virtually all 
cases (99%) had progressed to temporal pallor of the disc, and loss of papillo-macular 
bundle. This is consistent with previous reports on chronic cases (Plant et al., 1997). 
Neurological disorder
We found a higher prevalence of signs of peripheral neuropathy among the studied 
cases than in earlier studies (Plant et al., 1997, Johnson e al., 1991).
52% of Tanzanian cases and 59% of the Somalian cases reported having burning 
sensations or numbness at the lower limbs. Neurological assessment indicated that 35% 
had signs of peripheral neuropathy at presentations in Tanzania.
These were mainly increased vibratory and thermal thresholds in the legs, suggesting 
the involvement of small nerve fibres in addition to the large myelinated fibres most 
often involved in toxic or metabolic neuropathies. (Plant et al., 1997).
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Auditory symptoms and signs
Symptomatic hearing loss had occurred in 31.5% of Tanzanian cases and 28% of 
Somalian cases . Audiometric assessment in Tanzania revealed that 66% of patients had 
sensorineural hearing loss. This indicates that over 34% of patients had asymptomatic 
hearing loss associated with the optic neuropathy.
Other features
Virtually all cases were from low income housing areas. All cases did not have 
treatment prior to the study. Because of this, together with the range of intervals 
between onset of disease and presentation, the baseline presentation data provides a 
cross-sectional view of the natural history for the first 12 weeks of the disease, in the 
absence of any intervention. Greatest loss of vision occurs during the first 2-4 weeks, 
without treatment, visual acuity continued to decline over the first 8 weeks of the 
disease process. Multivariate analysis showed that there were no predictors of disease 
severity at presentation. This disease is clinically identical to the Cuban optic 
neuropathy ( Sadun et al., 1994; Thomas et al., 1995). The age distribution in the 
Tanzanian epidemic and in Somalia, however, is distinct as a younger age group has 
been affected than in the Cuban epidemic ( Mean age was: Tanzanian cases : 25.5 years, 
Somalian cases: 24 years, while for the Cuban cases, it was 45 years) (The Cuba 
neuropathy field investigation team 1995). Other major differences between the 
Tanzanian and Somalian cases versus the Cuban cases were, the fact that smoking was 
widespread among the Cuban patients ( 83% of them smoke cigarettes), compared to 
13.3% of smokers among the Tanzanian cases and 9.5% among the Somalian cases. A 
very common feature in the Cuban epidemic has been weight loss ( 1 0 - 2 0  Kg) 
coincident with the onset of symptoms ( Thomas et al., 1995), 44.7% of Somalian cases 
and only 21.3% of the Tanzanian patients had reported weight loss.
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The peripheral neuropathy appears to develop either slowly or at a later stage to the 
optic neuropathy. This suggests the peripheral neuropathy may have a slightly different, 
but probably overlapping aetiology.
The present epidemic has many features which overlap with previous reports of optic 
neuropathy, peripheral neuropathy and deafness occurring in the context of poor 
nutrition usually in the tropics ( Strachan’s syndrome). Apart from the association with 
poor nutrition the aetiology of the disorder is unknown.
Epidemics of neuropathy have been reported primarily during wartime, especially 
among prisoners of war in Asia during World War II (Spillane JD 1947). An epidemic 
in which clinical abnormalities were identical to those in the 1991-1993 Cuban 
epidemic was reported in Havana during the Spanish-American war (Madan D 1898). 
Although the cause of these earlier epidemics was never established, contemporary 
neurologists linked them to dietary deprivation and lack of B-complex vitamins 
(Spillane JD 1947), and Tobacco use was implicated in optic neuropathy among 
prisoners of war (Knox et al., 1982).
In Africa, exposure to cyanide from cassava consumption has been implicated in 
epidemics of neurological disease. However, unlike those in this Tanzanian epidemic, 
affected subjects have usually had spastic paraparesis ( Mozambique, Ministry of Health 
1984). There is greater overlap with Tropical Ataxic neuropathy (TAN) which has been 
attributed to chronic cassava consumption (Osuntokun, 1981), but the present study 
shows low levels of cassava consumption in the cases, as only 20% of cases consume it 
more than three times a week.
Although we cannot assign a definitive cause to this epidemic, our findings suggest that 
its occurrence was linked to deterioration in diet affecting vitamin B nutrients.
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5C- Etiological Studies:
5C1: Cyanide intoxication:
These results are within the range seen in healthy individuals; they are similar to the 
results obtained in chronic cases and controls previously (Plant et al., 1997).
These results should be compared with published mean serum and urine thiocyanate 
levels of 307 and 904 pmol/L respectively in a Zairian population which is consuming a 
high dietary proportion of bitter cassava. This population was affected by the spastic 
paralysis attributed to cyanide intoxication known as konzo. (Tylesskar et al., 1992).
The suggestion that cyanide intoxication may be implicated in the pathogenesis of optic 
neuropathy in some cases had been repeated in literature with reference to both smoking 
and cassava consumption. Indeed both cassava consumption and smoking were found to 
be risk factors in the Cuban epidemic (The Cuban Optic Neuropathy Field Investigation 
Team, 1995). Very few young Tanzanians smoke tobacco but the consumption of 
cassava in the city has increased in recent years.
The strength of this study is that we were working on acute cases with recent onset of 
disease. We now confirm beyond any doubt that the population at risk of developing 
epidemic optic neuropathy in Tanzania is subjected to very low levels of cyanide 
exposure from all sources and that there is no evidence of acute exposure associated 
with disease onset.
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5C2: Leber’s hereditary optic neuropathy:
We know of no information in the literature suggesting that black African populations 
may harbor different mutations from those seen in Caucasians, the evidence from Cuban 
black and Caucasian populations is to the contrary ( Torroni et al., 1995).
Studies in Cuban optic neuropathy cases found that many patients with LHON, which 
started at the time of the epidemic , were incorrectly classified as suffering from this, 
and perhaps their condition worsened due to the toxic nutritional features common to 
both conditions (Santiesteban et al., 1995).
Mitochondria DNA can be impaired either genetically ( as in Leber’s) or through 
acquired insults ( such as nutritional or toxic factors). Either may challenge energy 
production in all cells of the body (Sadun A 1995).
Our results show with great rigor that common mitochondrial DNA mutations seen in 
LHON are not risk factors for the development of Tanzanian Epidemic Optic 
Neuropathy. The most common mitochondrial DNA mutations associated with LHON 
did not appear to be contributing factors in the epidemic neuropathy in Cuba ( Newman 
et al., 1994; Torroni et al., 1995).
5C3: Vitamin status of Tanzanian ON cases and controls
Nutritional deficiency of vitamins results in inhibition of key metabolic pathways. 
Deficiencies in the production of important enzymes, coenzymes (such as FAD, FMN 
and ATP) or compound carriers play a role in the starvation of metabolic fuel from the 
nerve cells, resulting in the so called “neural metabolic lesion”. There exists in neurons 
a threshold which, once passed, leads to catastrophic changes. This threshold may be 
that point at which mitochondrial derangement leads to such ATP depletion that axonal 
transport is compromised. Neurons are singularly dependent on the axonal transport of 
mitochondria ( Sadun A 1995).
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The presence of riboflavin deficiency among both cases and controls suggests that 
riboflavin deficiency on its own is not sufficient to produce the optic neuropathy. 
Riboflavin deficiency may be part of a multi-factorial aetiology.
The clear deficiency in retinol and tocopherol levels of the Tanzanian samples 
compared to the British samples in the NDNS study are likely due to either: differences 
in total plasma lipids,, especially for the tocopherols; age differences, especially for 
retinol; possibly differences in acute phase status, since the acute phase reaction lowers 
plasma retinol levels; Possibly differences in dietary intakes of these nutrients.
The higher lutein and lycopene levels in the Tanzanian subjects are, however, quite 
likely to be diet-related, because these carotenoids are fairly good markers of 
carotenoid, and hence vegetable intakes and they are not converted to vitamin A in the 
body.
This study is the first time that acute cases have been tested for micronutrient 
deficiency, and is the first clear demonstration of an identifiable abnormality which may 
be of etiological significance.
Identical Thiamine (Bi) and Riboflavin (B2) deficiencies among cases and controls, 
suggests that a B-complex deficiency on its own is not sufficient to produce the 
neuropathy. Measurements of urinary thiamine and blood transketolase and its 
activation with thiamine pyrophosphate were made in Cuban ON cases and controls ( 
Macias-Motos et al., 1995). The Cuban samples showed a high prevalence (30-70%) of 
thiamine depletion. Severity of biochemical depletion was, however, no greater in the 
neuropathy subjects than in the control subjects ( P > 0.05). Studies in Cuba confirmed 
the high prevalence of poor B-vitamin status and have produced new evidence about the 
complex seasonal cycles of micronutrient availability and biochemical status in men 
living in Havana ( Amaud et al. 2001 a,b).
I l l
They have also demonstrated a dramatic deleterious effect of smoking on riboflavin 
status and on some (but not all) classes of serum carotenoids, and a smaller but 
significant effect on total serum protein (but not serum albumin) (Bamouin et al., 
2000).B-complex deficiency is part of a multi-factorial aetiology.
Nutritional shortages that lead to a reduction of folates, and the intake of small amounts 
of methanol in alcoholic drinks could lead to a lacking energetic states which would 
facilitate that the optical nerve be affected and the epidemic optical neuropathy appear 
in Cuba ( Elies et al., 2000). In contrast the Tanzanian samples had normal folate 
concentration, and were not consumers of alcohol drinks.
Vitamin B 12 serum levels did not differ significantly between cases and controls, and 
they had normal serum concentration. In Cuba it was hypothesized that vitamin B12 
participated to the etiological pathway through its cyanide detoxification capacity, but 
the vitamin was not a precipitating factor (Bamouin et al., 2000).However, if an insult 
such as exposure to cigarette smoke were to alter the tissue distribution or balance of 
coenzyme and/or non coenzyme forms of the vitamin, then a functional deficiency at a 
critical site might arise even in the presence of an apparently normal serum 
concentration ( Chisholm et al., 1967). The implication is that we may need to develop 
more discriminatory biochemical indices in order to resolve such uncertainties.
There was no difference of fat soluble vitamins levels among the Tanzanian cases and 
controls. The Tanzanian samples were deficient in retinol and tocopherol levels 
compared to British samples. It is well known that carotenoids have antioxidant roles to 
defend neural cells against toxic agents. Although levels of toxic metabolite of cassava 
were not raised in the studied cases, it may be that a similar mechanism is operating 
here, i.e. A deficiency of one dietary component leading to defective handling of 
another.
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Nearly all circumstantial clues seem to point in the direction of malnutrition as being an 
important component of the risk complex, with a number of micronutrient deficiencies 
being on the list of suspects. In the Cuban epidemic widespread distribution of vitamin 
supplements led to a virtual cessation of new cases .
Whether the B-vitamins with their coenzyme roles, or nutrients such as specific 
carotenoids and amino acids with their antioxidant roles, are the prime suspects, is still a 
matter for speculation.
5D: Treatment study:
Prior to this study, our understanding of the Tanzanian epidemic optic neuropathy was 
largely based on chronic cases examined many months after disease onset. Nothing was 
known about the benefits of B-complex supplement on disease prognosis.
There were significant improvements in visual acuity. 76% and 91% of cases had 
gained vision at 1 month and 3 months follow-up respectively. At 3 month follow-up, 
only 9% of cases had the same visual acuity they had at presentation, and there was no 
single case with vision deterioration at this stage.
There were similar improvements in colour vision, as the proportion of cases able to 
read 10 or more Ishihara plates were 34%, 67% and 70% at presentation, 1 month and 3 
months after vitamin supplements.
Earlier studies from Tanzania have documented that without intervention, only 10 - 20  
of cases have spontaneous recovery ( Johnson et al 1993).
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66% of cases presented with at least 20 dB broad spectrum loss of sensorineural hearing 
loss. After 1 month of vitamin supplements, only 18.2% of cases had sensori-neural 
hearing loss, and at three months follow-up 9.9% of cases had sensor-neural hearing 
loss on audiometry. This is indeed a significant improvement of the hearing sense. 
Neurological assessment indicated that 35.5% of cases had signs of peripheral 
neuropathy at presentation. At the one month follow-up clinic, the proportion of cases 
with signs of peripheral neuropathy had increased to 37.9%. This increase was due to 27 
cases developing neurological signs after presentation to the clinic. At the 3 month 
follow-up, the proportion with signs of peripheral neuropathy had decreased to 27%. 
The peripheral neuropathy appears to develop either slower or at a later stage to the 
optic neuropathy.
All cases received no treatments or medicines between disease onset and presentation to 
the clinic. Vitamin supplements have resulted in substantial visual recovery for over 
90% of the Tanzanian epidemic optic neuropathy.
In Cuba a temporal association was noted between the decline in cases and the 
distribution to the entire population of Cuba of a vitamin supplement containing B- 
group vitamins, folate, and vitamin A. Distribution began in the first week of May,
1993. During the last semester of 1993 incident cases gradually abated and by the years 
end the epidemic vanished.(Roman et al., 1994).
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5 E: Conclusions and Recommendation for future studies:
The epidemic of optic neuropathy is still ongoing in Dar es Salaam, Tanzania (personal 
communication), and there are signs of the disease in Mogadishu, Somalia.
This epidemic has very strong similarity to the Cuban epidemic of optic neuropathy that 
occurred in early 90s, and our conclusion is that they are the same entity.
This study has demonstrated that the epidemic is treatable with vitamin B-supplements.
The fact that cases did not differ from controls with respect to many of the nutritional 
factors explored, can be explained by “Rose hypothesis” outlined in his paper “sick 
individuals and sick populations” as large sectors of the population may be deficient 
(explaining the high incidence of disease) (Rose 2001).
Aetiology confronts two distinct issues: the determinants of individual cases, and the 
determinants of incidence rate. If exposure to a necessary agent is homogeneous within 
a population, then case/control and cohort methods will fail to detect it.
The community’s immediate needs to cope with this huge outbreak are:
• training of community eye care workers on how to diagnose the disease,
• establish a surveillance system in community health clinics to provide 
data on patterns of disease occurrence and to monitor changes in the 
epidemic pattern,
• develop guidelines for the health services for treating existing cases and 
preventing new cases from occurring,
• Initiate community intervention strategies, with a mass distribution of 
vitamin B-complex supplements to halt the epidemic.
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Cystine is an amino acid that exists in both oxidized ( cystine) and reduced forms.
Plasma contains mainly the oxidized form, while the major cellular form of the 
compound is the reduced form cysteine. This compound is utilized intracellulary for a 
variety of metabolic roles, most specifically for the biosynthesis of gluatathione. 
Glutathione is a major cellular antioxidant and exists in neural tissues at considerable 
concentrations. There is compelling evidence that plasma-borne cystine is the primary 
source of intracellular cysteine. Thus a deficiency of plasma cystine would be expected 
to result in a deficiency not only of intracellular cysteine itself, but chronically to result 
in a deficiency of cysteine-derived metabolic products. It is likely that the most 
important of these products would be glutathione.
Preliminary data from analysis of the free amino acids of blood plasma ( cases= 
14,controls=14), revealed that samples from the diseased subjects were seriously 
deficient in the cystine and that this effect was specific to this amino acid alone. The 
content of methionine in all the plasma samples tested was lower than would be 
expected from subjects consuming western diets.
Low plasma methionine concentration suggests that all subjects whose plasma was 
analyzed in this study had previously consumed diets that were deficient in the sulphur- 
containing amino acids ( methionine and cysteine).
The deficiency in cystine in the plasma samples from those affected subjects is 
enormous, even greater than plasma samples in experiments in which diets deficient in 
sulphur amino acids were consumed by human volunteers. A number of mechanisms 
might bring about this situation:
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a- Much methionine (perhaps as much as 90%) is converted to cystine + 
cysteine in vivo, and this material will contribute to the plasma 
concentration of cystine. Hence a dietary compound that inhibited this 
conversion could lead to a diminution in the concentration of plasma 
cystine.
b- Food-derived compounds could react with plasma cystine directly and 
cause the observed removal of cystine from plasma. Such substances 
include cyanide and sulphite.
It has previously been demonstrated that deficiency of amino acids in the blood can lead 
to defective detoxification after cassava consumption (Tor-Agbidye et al., 1998).The 
association between high cyanide and low sulphur intake in cassava-induced spastic 
paraparesis has been demonstrated (Cliff et al., 1985).
As the amino acid content of plasma is directly related to the food intake, it would be 
appropriate to analyse amino acid plasma levels immediately after a meal.
The study in Mogadishu did not have the aetiological component, as political situation 
there did not permit for the transportation of urine and blood samples to London. But 
there is a great hope that the political situation in Mogadishu, improves in the near 
fixture.
Further studies are needed to ascertain amino acid levels of cases and control, either 
from Tanzania or Somalia. Clinical trials involving two alternative treatments will be 
needed to further analyse the impact of vitamin supplements to this disease.
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Name__
Address
Appendix 1: Epidemic Optic Neuropathy -  Clinical examination record
______  Age_______ yrs Sex______ Clinic_____________________  Case No
Visit 1 Visit 2 Visit 3
Examination Date____________________________ ________________  ___________________  __________ _
Time since disease onset________________________________________  ___________________  ____________
Ophthalmic Examination
Corrected Visual Acuity: Right eye______________ __________________  __________________  ____________
Left eye________________________________  __________________  ____________
Colour vision Right eye __________________  __________________  _____________
Colour field Right eye _______  ___________  _________
Left eye _______  __________  _________
Amsler Right eye _______  __________  _________
Left eye_______________________  ___________  _________
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Name
Ophthalmic Assessment
Visit 1 
R L
Pupillary response 
Optic Disc
Normal
Blurred margins 
Dilated capillaries 
Temporal pallor
Temporal pigment accumulation
Atrophy
Other
Case No
Visit 2 
R L
Visit 3 
R L
136
Name
Visit 1 
R
Nerve fibre layer Normal
Loss of PMB 
Hypertrophy 
Loss of foveal reflex 
Other
Fundus Photograph
Visit 2
Case No
Visit 3
R L R L
Name
Neurological Examination
Visit 1
Tandem walking
R L
Vibration sensation at ankles
Cotton wool sensation in lower limbs
Pin prick sensation in lower limbs
Temperature sensation in lower limbs
Joint position sense
Knee jerk
Ankle jerk
Heel shin ataxia
Rinne’s test
Audiometry
138
Case No
Name
Neurological questions
Visit 1 
R L
Burning sensation in your feet 
Constant 
Intermittent 
Occasional 
Numbness in legs 
Constant 
Intermittent 
Occasional 
Difficulty hearing 
Constant 
Intermittent
139
Visit 2
Case No
Visit 3
R L R L
Occasional
Name_________ ___________ __________________
Visit 1
Difficulty walking 
Constant 
Intermittent 
Occasional 
Difficulty controlling bladder 
Constant 
Intermittent 
Occasional 
Difficulty in memory 
Constant 
Intermittent 
Occasional
Visit 2
Case No
Visit 3
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Name Case No
Events at time of visual impairment
Occupation  ______________ _Case
Spouse
_________________ Father
Pregnant _________
Breastfeeding ___________
Eye Pain ___________
Burning sensation in your feet 
Numbness in legs 
Difficulty hearing 
Difficulty walking 
Difficulty controlling bladder
Industry
Difficulty in memory 
Weight loss 
Did you smoke?
How many cigarettes per day?
Did you drink alcohol?
How much per week?
Did you eat cassava?
How often per week?
Did you take chloroquine?
Time for vision to reach its worst point_______ days________ weeks  months
Name  ______________________________  Case__________
Lifestyle questions 
How often do you eat fish?
How often do you eat meat?
Foods normally eaten ( at time of first visit)
142
Morning
Beverages
Afternoon Evening
143
Blood specimen 
Urine specimen
Appendix 2: Instruction Codes for Optic Neuropathy Study Questionnaire
Age:
S ex :
Case No:
Time since onset:
Visual Acuity:
Colour Vision: I 
Colour field and Amsler : 
Pupillary response:
Optic Disc:
Nerve Fibre Layer: 
Neurologic Examination:
in years
M for Males, F for females 
Serial Number 
In weeks 
Snellen chart 
Ishihara test
1 :Normal, 2 central scotoma 3 centrocecal scotoma, 4 other 9 Not done 
1 Normal 2 slow, 3 RAPD
1 Normal, 2 blurred margins, 3 dilated capillaries, 4 temporal pallor, 5 temporal pigmentation 6 atrophy, 7 other 
1 Normal, 2 loss of PMB, 3 hypertrophy, 4 loss of foveal reflex, 5 other 
1 normal, 2 abnormal, 9 not done
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Audiometric examination: 1 normal, 2 mild loss, 3 severe loss
neurological symptoms: 1 yes, 2 no
Lifestyle questions: 1 every day, 2 at least once a week, at least once a month, 4 less than once a month
Urine/blood samples 1: taken, 2: Not taken
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